https://www.pharmaceutical-business-review.com/news/gsk-submits-snda-for-promacta-to-fda-for-severe-aplastic-anaemia-treatment-030314-4188314/ 2014-03-03T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/acucela-closes-patient-enrollment-in-phase-iibiii-trial-of-emixustat-hydrochloride-040314-4188471/ 2014-03-03T23:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ohr-pharmaceutical-and-cshl-announce-joint-venture-to-develop-trodusquemine-and-related-analogs-040314-4189588/ 2014-03-04T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-biopharma-launches-galena-patient-services-040314-4188843/ 2014-03-04T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/simulations-plus-signs-research-collaboration-agreement-with-fda-040314-4188855/ 2014-03-04T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/intelgenx-and-redhill-biopharma-submit-response-to-fda-crl-for-versafilm-product-040314-4188864/ 2014-03-04T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/vida-canada-contracts-to-purchase-production-plant-040314-4188870/ 2014-03-04T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-announces-strategic-collaboration-and-funding-with-taxus-pharmaceuticals-040314-4188944/ 2014-03-04T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/genocea-biosciences-announces-collaboration-to-characterize-anti-tumor-t-cell-responses-in-melanoma-patients-040314-4189020/ 2014-03-04T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/heat-biologics-begins-dosing-patients-in-phase-iii-bladder-cancer-trial-of-hs-410-040314-4189278/ 2014-03-04T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/covance-and-business-review-free-webinar-series-offers-specialized-content-for-pharma-industry-professionals-040314-4189314/ 2014-03-04T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-pharmaceuticals-launches-adasuve-in-us-for-agitation-treatment-040314-4189188/ 2014-03-04T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-buys-astellas-pharmas-prescription-brand-vaprisol-040314-4189226/ 2014-03-04T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-buys-otc-products-from-aspen-global-for-51m-040314-4189257/ 2014-03-04T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-submits-ind-application-to-fda-to-initiate-oms721-phase-ii-clinical-program-050314-4189411/ 2014-03-04T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/argos-therapeutics-presents-new-data-from-clinical-research-for-ags-004-patient-specific-immunotherapy-in-hiv-treatment-050314-4189604/ 2014-03-05T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/xenetic-biosciences-opens-corporate-headquarters-and-rd-facility-in-massachusetts-050314-4189664/ 2014-03-05T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/synageva-biopharma-issued-us-patent-for-treatment-of-lal-deficiency-050314-4189676/ 2014-03-05T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/celerion-announces-expansion-of-clinical-operations-to-south-korea-050314-4189683/ 2014-03-05T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/chantest-opens-new-laboratory-facilities-for-expanded-cell-and-molecular-biology-services-050314-4189689/ 2014-03-05T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-initiates-voluntary-recall-of-zoledronic-acid-injection-050314-4189720/ 2014-03-05T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/biosyent-signs-licence-distribution-agreement-for-new-gastrointestinal-health-product-050314-4190087/ 2014-03-05T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/proteostasis-extends-collaboration-with-cfft-for-new-therapies-to-treat-cystic-fibrosis-050314-4190090/ 2014-03-05T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/harlan-crs-bertin-pharma-enter-drug-development-agreement-050314-4190115/ 2014-03-05T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-to-begin-phase-iv-trial-of-jetrea-in-us-to-treat-vmavmt-050314-4190201/ 2014-03-05T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/zs-pharma-closes-55m-financing-to-develop-new-treatments-for-hyperkalemia-060314-4190344/ 2014-03-06T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-biosciences-signs-medicare-part-d-prescription-drug-agreement-with-wellcare-060314-4190600/ 2014-03-06T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/agenus-to-advance-three-checkpoint-modulator-antibodies-into-development-060314-4190606/ 2014-03-06T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/antigen-express-receives-patents-for-vaccines-targeting-hpv-induced-cancers-and-influenza-060314-4190607/ 2014-03-06T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/quanticate-expands-global-operations-for-biostatistics-and-programming-in-clinical-trials-060314-4190613/ 2014-03-06T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/metabolon-enters-into-collaboration-agreement-with-human-longevity-to-provide-metabolomic-profiling-services-060314-4190619/ 2014-03-06T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/rxi-pharmaceuticals-gets-us-patent-related-to-self-delivering-technology-to-treat-fibrotic-disorders-060314-4190626/ 2014-03-06T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/regulus-therapeutics-initiates-dosing-of-rg-101-in-phase-i-study-060314-4190778/ 2014-03-06T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/probiogen-grants-license-of-glymaxx-adcc-enhancement-technology-to-meru-060314-4191191/ 2014-03-06T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biotech-to-start-phase-iii-daratumumab-trial-to-treat-myeloma-patients-060314-4191194/ 2014-03-06T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/alchemia-licenses-two-anticancer-drug-candidates-from-ctx-060314-4191198/ 2014-03-06T09:10:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-grants-conditional-approval-to-janssens-tb-drug-sirturo-070314-4191332/ 2014-03-07T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-voluntarily-recalls-depressive-disorder-drug-070314-4191570/ 2014-03-07T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-to-acquire-products-or-companies-to-expand-activities-at-martigny-manufacturing-facility-in-switzerland-070314-4191642/ 2014-03-07T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-biopharmaceuticals-closes-30m-loan-with-oxford-finance-070314-4191655/ 2014-03-07T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-pharmaceuticals-partners-with-shaanxi-university-of-chinese-medicine-to-co-develop-liver-cancer-drug-070314-4191667/ 2014-03-07T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/neostem-enters-into-sponsored-research-collaboration-with-massachusetts-eye-and-earschepens-eye-research-institute-070314-4191689/ 2014-03-07T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-reports-additional-positive-data-from-oms824-phase-iia-schizophrenia-clinical-trial-070314-4191709/ 2014-03-07T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ensysce-biosciences-receives-us-notice-of-allowance-for-delivery-of-sirna-070314-4191802/ 2014-03-07T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-endos-aveed-injection-for-hypogonadism-treatment-070314-4191922/ 2014-03-07T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pluristems-commercial-scale-cell-manufacturing-process-070314-4191932/ 2014-03-07T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/clintrax-selects-acorns-cloud-based-tracking-solution-trialcta-070314-4191950/ 2014-03-07T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alcobra-gets-fda-clearance-of-ind-for-metadoxine-extended-release-070314-4191955/ 2014-03-07T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-phase-iii-study-for-jakavi-in-polycythemia-vera-patients-100314-4192017/ 2014-03-09T23:10:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-new-drug-application-for-type-2-diabetes-drug-in-japan-100314-4192041/ 2014-03-10T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/targeted-medical-pharma-launches-e-prescribe-platform-for-theramine-100314-4192509/ 2014-03-10T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/torii-pharmaceutical-reports-positive-trial-results-for-house-dust-mite-slit-tablet-100314-4192724/ 2014-03-10T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/nw-bio-receives-recommendation-to-continue-with-phase-iii-gbm-brain-cancer-trial-100314-4192732/ 2014-03-10T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-announces-issuance-of-us-patent-for-use-of-trimesta-for-multiple-sclerosis-100314-4192757/ 2014-03-10T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-designates-regados-reg1-in-pci-as-fast-track-development-program-100314-4192767/ 2014-03-10T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/maxhealthlabs-intra-cellular-liposomal-curcumin-provides-potential-protection-against-prostate-cancer-100314-4192779/ 2014-03-10T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-and-university-college-london-to-work-on-muscle-disorders-research-100314-4192390/ 2014-03-10T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-generic-xeloda-tablets-in-us-100314-4192411/ 2014-03-10T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/c3-jian-initiates-phase-ii-study-of-anti-cavity-drug-c16g2-100314-4192533/ 2014-03-10T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-genetics-dsmc-recommends-continuation-of-phase-iii-pancreatic-cancer-clinical-study-with-algenpantucel-l-100314-4192603/ 2014-03-10T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cevec-pharma-reports-positive-data-from-rsv-vaccine-evaluation-program-110314-4192881/ 2014-03-10T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-announces-completion-of-dose-escalation-stage-of-phase-iii-study-for-celiac-disease-drug-110314-4193232/ 2014-03-11T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/scottish-medicines-consortium-says-yes-to-relapsing-remitting-multiple-sclerosis-drug-110314-4193436/ 2014-03-11T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-secures-direct-rights-from-temple-university-to-original-rhb-102-patents-100314-4192641/ 2014-03-11T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/marchesini-and-antares-vision-announce-commitment-to-irish-pharma-market-110314-4193590/ 2014-03-11T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-pharma-reports-top-line-results-from-phase-ii-study-of-chronic-kidney-disease-drug-110314-4193652/ 2014-03-11T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-lundbecks-submission-of-new-drug-application-for-intravenous-carbamazepine-110314-4193663/ 2014-03-11T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/macular-health-introduces-first-ocular-nutrition-oral-thin-film-delivery-method-110314/ 2014-03-11T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-expands-asia-pacific-operations-110314-4193697/ 2014-03-11T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-obtains-approval-for-pulmonary-arterial-hypertension-drug-110314-4193014/ 2014-03-11T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/argenta-achieves-milestone-in-anti-bacterial-drug-discovery-project-110314-4193494/ 2014-03-11T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/curevac-wins-eus-eur2m-inducement-prize-for-rnactive-vaccine-technology-110314-4193407/ 2014-03-11T10:15:00+00:00 https://www.pharmaceutical-business-review.com/news/caisson-biotech-expands-partnership-with-novo-nordisk-for-heptune-technology-110314-4193716/ 2014-03-11T12:45:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-diabetes-drug-xigduo-available-in-uk-120314-4193893/ 2014-03-11T23:17:00+00:00 https://www.pharmaceutical-business-review.com/news/sk3-groups-berkeley-bio-organic-research-laboratories-develops-alzatrex-120314/ 2014-03-12T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-announces-issuance-of-us-patent-for-trimesta-120314-4194405/ 2014-03-12T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-connects-to-exostars-life-sciences-cloud-collaboration-platform-120314-4194413/ 2014-03-12T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-technology-supports-pharmacyclics-in-achieving-early-approval-of-imbruvica-120314-4194425/ 2014-03-12T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/access-pharmaceuticals-announces-mugard-license-agreement-with-hanmi-pharmaceutical-in-korea-120314-4194436/ 2014-03-12T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/iwt-awards-3m-grant-to-thrombogenics-for-diabetic-macular-edema-research-120314-4194394/ 2014-03-12T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-ucb-enter-into-drug-development-partnership-120314-4194687/ 2014-03-12T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-naloxone-hydrochloride-injection-120314-4194689/ 2014-03-12T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-gets-third-australia-patent-for-oral-exenatide-120314-4194691/ 2014-03-12T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/tc-biopharm-medinet-to-develop-new-cancer-therapies-120314-4194672/ 2014-03-12T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/neuroderm-starts-enrolling-patients-in-second-phase-ii-trial-of-nd0612-to-treat-pd-120314-4194683/ 2014-03-12T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-mepolizumab-meets-primary-endpoint-in-two-phase-iii-asthma-trials-130314-4194755/ 2014-03-12T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-enters-into-reimbursement-agreement-with-uhg-and-optumrx-for-zubsolv-130314-4195001/ 2014-03-13T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/clinicalrm-awarded-barda-contract-to-support-medical-countermeasures-clinical-studies-network-130314-4195015/ 2014-03-13T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-signs-material-transfer-agreement-with-gbb-for-niagen-research-130314-4195097/ 2014-03-13T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/burmans-leverages-pioneering-treatment-management-solution-to-improve-hepatitis-c-outcomes-130314-4195128/ 2014-03-13T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/aegis-intravail-technology-enhances-oral-bioavailability-of-tableted-otc-drugs-130314/ 2014-03-13T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/igi-laboratories-lidocaine-hydrochloride-topical-solution-gets-fda-approval-130314/ 2014-03-13T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-upsher-smiths-antiepileptic-drug-qudexy-xr-130314/ 2014-03-13T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodts-pain-drug-xartemis-xr-gets-us-fda-approval-130314/ 2014-03-13T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-to-expand-manufacturing-capacities-for-hemophilia-a-products-in-germany-130314/ 2014-03-13T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-launches-generic-version-of-neptazane-tablets-130314/ 2014-03-13T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-university-of-cambridge-enter-into-oncology-research-collaboration-130314/ 2014-03-13T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-healthcare-initiates-phase-iiib-riociguat-trial-in-pah-patients-140314-4195709/ 2014-03-14T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-announces-opening-of-newly-designated-asian-bridging-clinical-trials-unit-140314-4196063/ 2014-03-14T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-sciences-to-acquire-bhv-pharma-140314/ 2014-03-14T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/saama-jump-starts-sales-operations-and-drug-commercialization-for-life-science-companies-140314-4196158/ 2014-03-14T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-pharmaceuticals-and-ferrer-announce-launch-of-adasuve-in-romania-140314-4196171/ 2014-03-14T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-pharmaceuticals-announces-expansion-of-pipeline-into-two-orphan-autoimmune-diseases-140314-4196184/ 2014-03-14T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/alvotech-finesse-enter-into-bio-manufacturing-collaboration-140314-4196397/ 2014-03-14T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/tesaro-anaptysbio-enter-into-license-deal-for-multiple-immuno-oncology-programs-140314/ 2014-03-14T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-obtains-clinical-recommendation-in-australia-for-bexsero-140314/ 2014-03-14T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/eveon-leti-demonstrate-liquid-pumping-for-smart-drug-delivery-140314/ 2014-03-14T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-md-anderson-partner-to-advance-cancer-immunotherapy-140314-4196606/ 2014-03-14T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-build-100m-purification-plant-in-denmark-170314/ 2014-03-16T23:13:00+00:00 https://www.pharmaceutical-business-review.com/news/simulations-plus-announces-success-in-cox-2cox-1-drug-design-project-170314-4197534/ 2014-03-17T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/repros-allowed-to-conduct-phase-i-and-ii-clinical-studies-of-oral-proellex-180314-4198480/ 2014-03-17T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicomm-systems-signs-25m-deal-with-biotechnology-company-180314-4198497/ 2014-03-17T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/alvotech-and-finesse-announce-exciting-bio-manufacturing-collaboration-170314-4197650/ 2014-03-17T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eliquis-to-reduce-risk-of-blood-clots-following-hip-or-knee-replacement-surgery-170314/ 2014-03-17T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-pharmaceuticals-initiates-voluntary-nationwide-recall-of-velaglucerase-alfa-for-injection-170314-4197667/ 2014-03-17T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/intercept-pharmaceuticals-phase-iii-poise-trial-meets-primary-endpoint-170314/ 2014-03-17T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-results-of-phase-iii-melanoma-trial-170314/ 2014-03-17T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-gets-fda-approval-for-intravenous-use-of-noxafil-injection-170314/ 2014-03-17T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-gets-us-patent-covering-use-of-bl-8040-in-immunotherapy-170314/ 2014-03-17T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/edisons-epi-743-gets-fda-fast-track-status-to-treat-friedreichs-ataxia-180314/ 2014-03-17T23:12:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-and-uc-san-francisco-to-evaluate-cancer-immunotherapy-constructs-in-prostate-cancer-180314-4198521/ 2014-03-18T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-announces-israeli-approval-of-phase-ii-study-protocol-for-cf102-180314-4198542/ 2014-03-18T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-establishes-research-and-development-team-and-opens-new-laboratory-180314-4198561/ 2014-03-18T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-therapeutics-becomes-taxus-cardium-pharmaceuticals-group-180314-4198582/ 2014-03-18T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/amorfix-and-trellis-bioscience-to-collaborate-on-anti-cd38-antibody-treatment-for-cancer-180314-4198609/ 2014-03-18T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-millipore-and-sysmex-announce-collaboration-for-flow-cytometry-technology-180314-4198654/ 2014-03-18T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-five-prime-to-develop-new-immuno-oncology-therapies-180314-4198868/ 2014-03-18T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-lundbeck-launch-schizophrenia-drug-abilify-maintena-in-europe-180314-4198908/ 2014-03-18T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bioheart-enters-into-joint-venture-with-magnum-cell-therapies-180314-4198918/ 2014-03-18T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirins-poteligeo-injection-approved-for-ptcl-and-ctcl-in-japan-180314-4198919/ 2014-03-18T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bioasis-licenses-transcend-platform-to-medimmune-180314-4198920/ 2014-03-18T09:20:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-vodafone-partner-to-provide-mobile-health-patient-services-190314-4198989/ 2014-03-18T22:58:00+00:00 https://www.pharmaceutical-business-review.com/news/oslo-brs-asa-implements-next-generation-otc-derivatives-platform-from-baymarkets-190314-4199300/ 2014-03-19T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-receives-patent-in-japan-for-adxs-hpv-for-treatment-of-cervical-cancer-190314-4199309/ 2014-03-19T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/genspera-announces-enrollment-of-first-patient-in-genspera-g-202-phase-ii-glioblastoma-trial-190314-4199320/ 2014-03-19T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/growlife-vape-holdings-announce-joint-venture-to-fund-and-develop-processes-for-cannabis-extractions-190314-4199329/ 2014-03-19T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pharma-two-b-commences-phase-iib-study-of-p2b001-for-parkinsons-disease-190314-4199347/ 2014-03-19T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/verde-media-biotechnology-adds-new-microbial-technology-to-produce-marijuana-oils-190314-4199342/ 2014-03-19T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/manhattan-scientifics-azano-biotech-collaborate-to-commercially-introduce-nanomrx-nanoparticles-190314-4199389/ 2014-03-19T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/swiss-agency-approves-thrombogenics-jetrea-to-treat-vitreomacular-traction-190314-4199658/ 2014-03-19T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-medivation-seek-us-fda-approval-for-xtandi-to-treat-mcrpc-190314-4199720/ 2014-03-19T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/igenica-doses-first-patient-in-phase-i-trial-of-ign523-to-treat-acute-myeloid-leukemia-190314-4199814/ 2014-03-19T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/emmaus-life-sciences-reports-results-of-phase-iii-trial-for-sickle-cell-disease-210314-4200912/ 2014-03-19T23:10:00+00:00 https://www.pharmaceutical-business-review.com/news/heat-biologics-submits-revised-phase-ii-clinical-trial-protocol-to-fda-for-nsclc-drug-210314-4200945/ 2014-03-19T23:15:00+00:00 https://www.pharmaceutical-business-review.com/news/nygc-ibm-watson-group-announce-collaboration-to-advance-genomic-medicine-210314-4200964/ 2014-03-19T23:25:00+00:00 https://www.pharmaceutical-business-review.com/news/collegium-pharmaceutical-announces-allowance-of-new-claims-covering-deterx-210314-4200992/ 2014-03-19T23:35:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-and-daiichi-sankyo-form-compound-library-sharing-partnership-210314-4201004/ 2014-03-20T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/xstalbio-launches-new-analytics-vaccine-service-200314-4199963/ 2014-03-20T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/falk-pharma-secures-rights-of-medigenes-rhudex-200314-4200134/ 2014-03-20T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-expands-global-clinical-logistics-services-200314-4200589/ 2014-03-20T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-sk-chemical-to-develop-new-pneumococcal-conjugate-vaccine-200314-4200762/ 2014-03-20T09:29:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-to-settle-patent-litigation-of-daytrana-with-noven-pharmaceuticals-200314-4200767/ 2014-03-20T09:29:00+00:00 https://www.pharmaceutical-business-review.com/news/portola-pharmaceuticals-starts-phase-iii-trial-of-andexanet-alfa-200314-4200776/ 2014-03-20T09:29:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-and-biowa-sign-licensing-agreement-with-argen-x-for-potelligent-technology-200314-4200780/ 2014-03-20T09:29:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-partners-with-lstm-and-uol-to-discover-new-anti-filarial-drugs-210314-4201012/ 2014-03-21T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/aibiotech-announces-acquisition-of-immunotox-210314-4201188/ 2014-03-21T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-announces-positive-interim-results-from-enchant-1-trial-of-ganetespib-210314-4201196/ 2014-03-21T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/multicell-technologies-files-us-and-international-patent-applications-for-treatment-of-liver-cancer-210314-4201209/ 2014-03-21T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-contracts-with-austrianova-for-cgmp-compliant-cell-in-a-box-encapsulation-of-cells-for-clinical-trials-210314-4201215/ 2014-03-21T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/concordia-healthcare-announces-agreement-to-acquire-donnatal-210314-4201224/ 2014-03-21T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-paladin-therapeutics-leishmaniasis-drug-210314-4201269/ 2014-03-21T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-oncology-regains-rights-to-av-203-from-biogen-210314-4201602/ 2014-03-21T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-launches-lucentis-pfs-in-germany-210314-4201632/ 2014-03-21T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/cortice-begins-phase-ii-tpi-287-avastin-combination-trial-for-glioblastoma-treatment-210314-4201677/ 2014-03-21T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-eagles-nda-for-ryanodex-210314-4201669/ 2014-03-21T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-magrit-trial-fails-to-meet-first-co-primary-endpoint-210314-4201689/ 2014-03-21T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinion-for-takeda-entyvio-to-treat-uc-and-cd-240314-4201855/ 2014-03-24T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/brainstorm-granted-key-us-patent-for-autologous-stem-cell-technology-240314-4202857/ 2014-03-24T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/nccn-receives-2m-in-research-funding-from-boehringer-ingelheim-240314-4202160/ 2014-03-24T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-recommends-novartis-bexsero-vaccine-for-inclusion-in-national-immunisation-programme-240314-4202216/ 2014-03-24T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/medivirs-simeprevir-receives-positive-chmp-opinion-in-eu-for-treatment-of-chronic-hepatitis-c-240314-4202232/ 2014-03-24T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/antisense-therapeutics-reports-completion-of-patient-enrollment-in-phase-ii-trial-of-atl1103-240314-4202256/ 2014-03-24T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-endocyte-announce-chmp-positive-opinions-for-platinum-resistant-ovarian-cancer-drug-240314-4202320/ 2014-03-24T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-pharma-to-return-global-rights-of-tozadenant-to-biotie-240314-4202493/ 2014-03-24T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-panel-issues-positive-opinion-for-boehringer-eli-lillys-type-2-diabetes-drug-empagliflozin-240314-4202526/ 2014-03-24T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/brazil-health-agency-approves-genzymes-lemtrada-to-treat-multiple-sclerosis-240314-4202531/ 2014-03-24T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/access-pharmaceuticals-advances-development-of-proctigard-for-radiation-proctitis-240314-4202201/ 2014-03-24T09:51:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-genentechs-urticaria-drug-xolair-gets-us-fda-approval-250314-4202645/ 2014-03-24T23:17:00+00:00 https://www.pharmaceutical-business-review.com/news/us-district-court-upholds-mylans-us-patents-on-perforomist-inhalation-solution-250314-4202860/ 2014-03-25T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/nanoviricides-announces-issuance-of-fundamental-patents-in-australia-and-philippines-250314-4203800/ 2014-03-25T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/kwazulu-natal-research-institute-and-ibm-research-fight-tuberculosis-in-south-africa-250314-4202895/ 2014-03-25T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/dyadic-international-gets-new-us-patent-250314-4202863/ 2014-03-25T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/scilex-pharmaceuticals-announces-filing-of-ind-application-for-ztilido-250314-4202978/ 2014-03-25T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-signs-definitive-agreement-to-acquire-cedarburg-pharmaceuticals-250314-4203027/ 2014-03-25T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-initiates-patients-dosing-in-phase-iia-trial-of-arc-520-to-treat-chronic-hepatitis-b-250314-4203308/ 2014-03-25T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-introduces-new-patent-pending-formulation-of-kerasal-nail-in-us-250314-4203316/ 2014-03-25T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-to-expand-product-line-by-developing-hemp-thc-free-cannabis-formulations-250314-4203319/ 2014-03-25T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/goodwin-aspyrian-partner-for-cgmp-manufacturing-of-new-antibody-drug-conjugate-250314-4203321/ 2014-03-25T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dainippons-latuda-gets-marketing-authorization-in-australia-to-treat-schizophrenia-260314-4203441/ 2014-03-25T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-announces-acceleration-in-sales-growth-with-new-tapout-product-order-260314-4203681/ 2014-03-26T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-pharmaceuticals-announces-key-patent-grant-for-zorvolex-260314-4203786/ 2014-03-26T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/swri-awarded-83m-contract-extension-for-continued-development-of-cyanide-antidote-260314-4203811/ 2014-03-26T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/noven-pharmaceuticals-announces-issuance-of-new-us-patent-for-brisdelle-260314-4203821/ 2014-03-26T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/sifi-and-novamedica-sign-agreement-to-market-eight-eye-care-products-in-russia-260314-4203840/ 2014-03-26T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-valeants-nda-of-metronidazole-13-vaginal-gel-gets-us-fda-approval-260314-4203876/ 2014-03-26T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/visivite-introduces-new-macular-health-formula-260314-4204761/ 2014-03-26T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-seeks-japanese-approval-for-regpara-125mg-tablets-260314-4204113/ 2014-03-26T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-receives-21m-grant-from-biomedical-catalyst-fund-260314-4203938/ 2014-03-26T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/n-of-one-biodiscovery-to-offer-integrated-genomic-analysis-interpretation-solutions-260314-4204195/ 2014-03-26T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-a1m-pharma-to-start-research-collaboration-for-new-mitochondrial-medicines-260314-4204213/ 2014-03-26T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/joslin-joins-oracle-health-sciences-network-to-expand-diabetes-research-collaboration-260314-4204219/ 2014-03-26T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithklines-once-weekly-diabetes-drug-eperzan-gets-marketing-approval-in-europe-270314-4204343/ 2014-03-27T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-inks-30m-in-eclinical-contracts-with-two-pharma-companies-270314-4204541/ 2014-03-27T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/biomaintenance-services-launches-new-extended-services-270314-4204585/ 2014-03-27T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/cytovance-precision-extend-cgmp-manufacturing-agreement-for-neo-102-drug-product-270314-4204608/ 2014-03-27T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-exercises-its-right-to-purchase-additional-shares-of-alnylam-common-stock-270314-4204612/ 2014-03-27T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/access-pharmaceuticals-cobraxane-offers-enhanced-tumor-growth-inhibition-in-tumor-models-270314-4204622/ 2014-03-27T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/e-therapeutics-announces-recruitment-resumes-into-uk-phase-i-ets2101-cancer-trial-270314-4204635/ 2014-03-27T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/scpharmaceuticals-completes-16m-series-a-financing-to-develop-two-product-candidates-270314-4204644/ 2014-03-27T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/neostem-signs-research-collaboration-agreement-for-treatment-of-skin-wounds-in-scleroderma-270314-4204696/ 2014-03-27T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-ibm-to-develop-transformative-care-coordination-solution-270314-4204748/ 2014-03-27T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/mast-therapeutics-begins-phase-ii-trial-of-acute-limb-ischemia-drug-mst-188-270314-4204982/ 2014-03-27T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-partners-with-kanpak-to-develop-store-brand-versions-of-ensure-270314-4204941/ 2014-03-27T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/xenon-genentech-to-develop-new-therapeutic-targets-for-treating-pain-270314-4204928/ 2014-03-27T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-takeda-partner-to-co-promote-gastrointestinal-drug-tak-438-in-japan-280314-4205313/ 2014-03-28T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-announces-new-tapout-product-order-from-biovea-280314-4205476/ 2014-03-28T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/retrophin-completes-acquisition-of-manchester-pharmaceuticals-280314-4205480/ 2014-03-28T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/rising-pharmaceuticals-to-acquire-pack-pharmaceuticals-280314-4205460/ 2014-03-28T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ibio-receives-patent-allowances-for-pandemic-influenza-therapeutics-280314-4205490/ 2014-03-28T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/cryolife-acquires-distribution-rights-for-procol-vascular-bioprosthesis-from-hancock-jaffe-laboratories-280314-4205493/ 2014-03-28T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/bioasis-receives-patent-allowances-for-lysosomal-storage-disease-therapeutic-in-europe-and-canada-280314-4205497/ 2014-03-28T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/pulmokine-receives-15m-stage-b-vita-contract-from-nhlbi-280314-4205502/ 2014-03-28T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-to-support-launch-of-biodeliverys-bunavail-in-us-280314-4205818/ 2014-03-28T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/nephrogenex-enters-into-research-collaborations-for-diabetic-nephropathy-drug-280314-4205850/ 2014-03-28T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-begins-patient-enrolment-in-us-phase-iia-trial-of-diabetes-drug-ormd-0801-280314-4205999/ 2014-03-28T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-to-invest-eur100m-in-beijing-production-plant-310314-4206160/ 2014-03-31T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/cilian-and-university-of-edinburgh-develop-malaria-vaccine-310314-4210128/ 2014-03-31T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/dia-organises-26th-annual-euromeeting-310314-4219030/ 2014-03-31T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/dainippon-takedas-schizophrenia-drug-latuda-gets-marketing-authorization-in-europe-310314-4206285/ 2014-03-31T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-starts-phase-iii-trial-of-pergoveris-in-poor-ovarian-response-patients-310314-4206289/ 2014-03-31T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-otc-drug-nexium-24hr-310314-4206292/ 2014-03-31T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-acquires-remaining-30-of-its-indonesian-consumer-healthcare-business-310314-4206294/ 2014-03-31T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-biogens-haemophilia-b-drug-alprolix-310314-4206295/ 2014-03-31T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/integral-molecular-announces-patent-protecting-use-of-lipoparticles-for-antibody-discovery-310314-4206298/ 2014-03-31T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/easton-signs-loi-for-joint-venture-towards-private-medical-marijuana-company-in-colorado-310314-4206300/ 2014-03-31T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/caris-life-sciences-improves-clinical-use-of-tumor-profiling-service-310314-4206302/ 2014-03-31T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/takedas-nda-for-cell-cultured-influenza-vaccine-approved-in-japan-010414-4206397/ 2014-03-31T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-mrc-enter-into-new-drug-discovery-collaboration-010414-4206454/ 2014-04-01T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-approval-of-cubists-sivextro-010414-4210075/ 2014-04-01T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-uses-novozymes-veltis-half-life-extension-technology-in-its-type-2-diabetes-drug-010414-4210079/ 2014-04-01T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/croma-pharma-signs-distribution-agreement-with-hugel-010414-4210087/ 2014-04-01T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/us-supreme-court-to-hear-tevas-appeal-on-copaxone-patent-010414-4206556/ 2014-04-01T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-and-trianni-sign-licensing-agreement-for-use-of-trianni-transgenic-mouse-platform-010414-4209516/ 2014-04-01T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-to-enter-into-a-partnership-with-lieber-institute-010414-4209540/ 2014-04-01T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-launches-adenosine-injection-in-two-preservative-free-vial-presentations-010414-4207005/ 2014-04-01T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-assigns-worldwide-rights-of-hematological-cancer-treatment-dacogen-to-otsuka-010414-4207036/ 2014-04-01T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/emig-welcomes-dh-funding-for-single-approval-system-for-clinical-research-010414-4207091/ 2014-04-01T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/palatin-extends-license-option-to-bremelanotide-in-europe-010414-4207097/ 2014-04-01T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/nccn-gets-22m-research-funding-to-study-enzalutamide-in-solid-tumors-010414-4207103/ 2014-04-01T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-seeks-japanese-approval-for-additional-indication-of-nesp-for-anemia-010414-4207099/ 2014-04-01T09:20:00+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-acquires-galapagos-cro-services-division-010414-4207101/ 2014-04-01T09:20:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-pfizer-and-broad-institute-partner-on-lupus-research-020414-4207219/ 2014-04-02T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-takes-over-silom-medical-company-020414-4207809/ 2014-04-02T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-expands-age-indication-of-sanofi-pasteurs-adacel-tdap-vaccine-020414-4207858/ 2014-04-02T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-launches-generic-version-of-taclonex-ointment-020414-4207819/ 2014-04-02T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-receives-notice-of-allowance-from-uspto-for-cancer-immunotherapy-platform-technology-020414-4209831/ 2014-04-02T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-new-drug-application-to-fda-for-darunavir-with-cobicistat-020414-4209833/ 2014-04-02T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/regenx-avexis-to-develop-new-treatment-for-sma-using-nav-raav9-vectors-020414-4207884/ 2014-04-02T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/cpdc-to-manufacture-azedra-for-progenics-pharmaceuticals-020414-4207919/ 2014-04-02T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/alacris-to-use-sap-hana-platform-for-modcell-system-020414-4207943/ 2014-04-02T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/eagles-exclusive-licensor-gets-us-patent-for-heat-stroke-drug-dantrolene-020414-4207946/ 2014-04-02T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-retains-td2-to-carryout-preclinical-clinical-studies-for-treatment-of-pancreatic-cancer-020414-4207951/ 2014-04-02T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-enters-into-joint-development-agreement-with-actavis-020414-4207954/ 2014-04-02T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-debiopharm-to-research-and-develop-new-cancer-treatments-030414-4208083/ 2014-04-03T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/glycotope-doses-first-patients-in-phase-iib-trial-of-cetugex-to-treat-scchn-030414-4208746/ 2014-04-03T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-starts-two-phase-iii-trials-of-simeprevir-sofosbuvir-combination-for-hepatitis-c-030414-4208901/ 2014-04-03T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/australian-tga-grants-anlit-gmp-certification-030414-4208909/ 2014-04-03T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-genetics-expands-biodiscoverys-nexus-copy-number-platform-030414-4208910/ 2014-04-03T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/mersana-gets-patent-with-broad-coverage-for-fleximer-adc-platform-technology-030414-4208912/ 2014-04-03T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/thorne-launches-niacel-to-support-healthy-aging-030414-4208914/ 2014-04-03T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/vgti-florida-scientists-gets-us-patent-for-pd-1-gene-expression-profiles-030414-4208916/ 2014-04-03T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-keryxs-marketing-authorization-application-for-zerenex-030414-4208862/ 2014-04-03T09:07:00+00:00 https://www.pharmaceutical-business-review.com/news/tetraphases-eravacycline-gets-fda-fast-track-status-030414-4208894/ 2014-04-03T09:07:00+00:00 https://www.pharmaceutical-business-review.com/news/novaliq-initiates-phase-i-study-of-cyclasol-eye-drops-040414-4209876/ 2014-04-03T19:15:00+00:00 https://www.pharmaceutical-business-review.com/news/dainippons-latuda-gets-approval-in-canada-to-treat-bipolar-depression-040414-4209058/ 2014-04-04T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-rejects-tevas-808-patent-reissue-application-on-copaxone-for-second-time-040414-4209213/ 2014-04-04T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/anaptysbio-announces-issuance-of-us-patent-covering-antibody-humanization-technology-040414-4209235/ 2014-04-04T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-announces-in-licensing-of-technology-from-strox-biopharmaceuticals-040414-4209250/ 2014-04-04T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-expanded-use-of-dyaxs-hae-drug-kalbitor-040414-4209760/ 2014-04-04T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-gets-approval-for-erectile-dysfunction-drug-vitaros-in-luxembourg-040414-4209820/ 2014-04-04T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/jpmas-sanctions-against-takeda-for-promotional-activities-of-case-j-040414-4209824/ 2014-04-04T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/kamada-starts-poc-study-of-glassia-to-treat-gvhd-040414-4209825/ 2014-04-04T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-kaleos-evzio-for-the-emergency-treatment-of-opioid-overdose-040414-4209836/ 2014-04-04T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-biopharma-submits-l-dos47-ind-application-with-fda-040414-4209838/ 2014-04-04T09:27:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-signs-licence-deal-with-akorn-for-marketing-of-tafluprost-in-us-070414-4210005/ 2014-04-07T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/spectromics-to-develop-novel-technology-for-effective-use-of-antibiotics-and-other-antimicrobial-therapeutics-070414-4211576/ 2014-04-07T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/noxxon-presents-positive-results-from-emapticap-pegol-phase-iia-diabetic-nephropathy-study-070414-4210220/ 2014-04-07T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-announces-availability-of-halaven-in-lebanon-for-treatment-of-metastatic-breast-cancer-070414-4210244/ 2014-04-07T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/diplomat-to-distribute-otezla-for-psoriatic-arthritis-070414-4210270/ 2014-04-07T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-filing-of-the-medicines-companys-us-biologic-license-application-for-fibrocaps-hemostatic-agent-070414-4210300/ 2014-04-07T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-completes-acquisition-of-cedarburg-pharmaceuticals-070414-4210306/ 2014-04-07T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-to-acquire-ranbaxy-laboratories-for-32bn-070414-4210367/ 2014-04-07T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/scripsamerica-to-market-childrens-pain-reliever-rapimed-in-canada-060314-4191189/ 2014-04-07T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-discovery-launches-new-genassist-crispr-and-raav-gene-editing-tools-and-services-080414-4210897/ 2014-04-07T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-releases-positive-paloma-1-trial-results-of-breast-cancer-combination-drug-070414-4210545/ 2014-04-07T09:11:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-signaling-introduces-new-pd-l1-antibody-for-cancer-immunotherapy-research-070414-4210552/ 2014-04-07T09:11:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-gets-fda-clearance-for-ind-application-of-thrombotic-microangiopathies-drug-070414-4210563/ 2014-04-07T09:11:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-files-ndas-to-fda-for-daclatasvir-and-asunaprevir-to-treat-hepatitis-c-080414-4210614/ 2014-04-07T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylams-mcswiggen-patent-upheld-in-european-opposition-proceedings-080414-4210876/ 2014-04-08T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/bocagreenmd-launches-generic-version-of-vitapearl-080414-4210878/ 2014-04-08T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-and-tga-strengthen-collaboration-in-area-of-orphan-medicines-080414-4210885/ 2014-04-08T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-pharmaceuticals-enters-into-co-production-partnership-with-patheon-for-exparel-080414-4210892/ 2014-04-08T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/tetralogic-pharma-to-acquire-shape-pharma-080414-4210999/ 2014-04-08T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/arno-starts-enrolling-patients-in-phase-iii-trial-of-onapristone-to-treat-prostate-cancer-080414-4211265/ 2014-04-08T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-patientslikeme-enters-research-collaboration-for-new-oncology-drugs-080414-4211269/ 2014-04-08T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-develop-new-adc-candidates-using-mersanas-fleximer-technology-080414-4211270/ 2014-04-08T08:58:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-pharma-gets-anda-approval-for-generic-procardia-xl-tablets-in-us-080414-4211273/ 2014-04-08T08:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-introduces-partial-onset-seizures-drug-aptiom-in-us-080414-4211276/ 2014-04-08T08:58:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-stemline-therapeutics-ind-application-for-brain-cancer-vaccine-090414-4211726/ 2014-04-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-pradaxa-gets-fda-approval-for-dvt-pe-treatment-090414-4211375/ 2014-04-09T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-announces-final-steps-for-its-clinical-trial-data-policy-090414-4211660/ 2014-04-09T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/elusys-completes-commercial-manufacturing-process-validation-for-anthrax-antitoxin-eti-204-090414-4211679/ 2014-04-09T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-achieves-milestones-from-takeda-for-achieving-first-commercial-sales-of-adcetris-090414-4211702/ 2014-04-09T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-pharmaceuticals-receives-notice-of-allowance-from-uspto-for-two-hormone-products-090414-4211740/ 2014-04-09T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/neuland-labs-opens-new-manufacturing-facility-in-india-090414-4212016/ 2014-04-09T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-bms-extend-partnership-to-provide-commercial-distribution-services-in-asia-090414-4212045/ 2014-04-09T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/prothena-starts-phase-i-trial-of-prx002-to-treat-parkinsons-disease-090414-4212053/ 2014-04-09T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-begins-enrollment-in-polish-phase-iii-trial-of-lung-cancer-drug-candidate-090414-4212055/ 2014-04-09T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/hyundai-hope-on-wheels-awards-2m-research-grant-for-projecteverychild-090414-4211587/ 2014-04-09T09:01:00+00:00 https://www.pharmaceutical-business-review.com/news/spero-therapeutics-announces-antibiotics-collaboration-with-roche-100414-4212333/ 2014-04-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vetter-launches-new-clinical-syringe-packages-100414-4212220/ 2014-04-10T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/vanda-makes-hetlioz-available-in-us-to-treat-non-24-hour-sleep-wake-disorder-100414-4212226/ 2014-04-10T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/oricula-therapeutics-secures-initial-funding-from-university-of-washington-100414-4212243/ 2014-04-10T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/first-aid-shot-therapy-launches-upset-stomach-100414-4212289/ 2014-04-10T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/dbv-technologies-announces-research-collaboration-agreement-with-cea-100414-4212298/ 2014-04-10T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/bioneutral-announces-sales-and-distribution-agreement-with-menzer-100414-4212302/ 2014-04-10T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-phase-iii-trial-of-schizophrenia-drug-aripiprazole-lauroxil-meets-primary-endpoint-100414-4212380/ 2014-04-10T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/clinipace-to-manage-clinical-programs-on-behalf-of-karyopharm-100414-4212598/ 2014-04-10T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-advances-development-of-first-cannabinoid-based-medicine-100414-4212620/ 2014-04-10T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/greenphire-ert-partner-to-strengthen-patient-compliance-for-clinical-trials-100414-4212642/ 2014-04-10T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-t1d-exchange-enter-research-collaboration-for-new-t1d-treatments-100414-4212656/ 2014-04-10T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-begins-phase-iib-trial-of-td-4208-to-treat-copd-110414-4212846/ 2014-04-11T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/american-cryostem-and-rutgers-university-file-joint-patent-on-adipose-derived-stem-cell-platform-technology-110414-4212848/ 2014-04-11T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/assembly-pharmaceuticals-biocrossroads-to-advance-potentially-curative-therapy-for-chronic-hepatitis-b-virus-110414-4212876/ 2014-04-11T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-announces-availability-of-new-advanced-parkinsons-treatment-in-canada-110414-4212898/ 2014-04-11T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fate-therapeutics-gets-us-patent-for-class-of-small-molecule-modulators-of-rho-associated-kinase-110414-4212915/ 2014-04-11T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-receives-milestone-payment-from-merck-110414-4212930/ 2014-04-11T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-engages-virusure-to-establish-cell-banks-for-phase-iib-clinical-trials-in-pancreatic-cancer-110414-4213013/ 2014-04-11T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-additional-patent-to-brainstorm-for-autologous-stem-cell-technology-110414-4212956/ 2014-04-11T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/vyrix-enters-into-agreement-with-paladin-for-exclusive-rights-of-zertane-in-canada-110414-4213479/ 2014-04-11T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-status-for-celladon-heart-failure-treatment-mydicar-110414-4213482/ 2014-04-11T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/coronado-starts-investigator-initiated-trial-of-tso-in-pediatric-patients-with-asd-110414-4213510/ 2014-04-11T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fate-gets-us-patent-for-class-of-small-molecule-modulators-of-rho-associated-kinase-110414-4213531/ 2014-04-11T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-resubmits-nda-for-parkinsons-disease-drug-rytary-to-us-fda-140414-4213741/ 2014-04-13T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-extends-market-exclusivity-for-biomarins-kuvan-powder-for-oral-solution-and-tablets-140414-4214644/ 2014-04-14T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/supreme-enters-into-negotiations-for-an-additional-medical-marijuana-producing-facility-140414-4214651/ 2014-04-14T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/federal-judge-enforces-settlement-agreement-between-mylan-and-endo-pharmaceuticals-regarding-generic-frova-140414-4214208/ 2014-04-14T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/enanta-pharmaceuticals-to-present-detailed-results-from-abbvies-pivotal-phase-iii-sapphire-i-study-140414-4214223/ 2014-04-14T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/dendreon-to-present-long-term-phase-ii-stand-study-at-eau-congress-140414-4214232/ 2014-04-14T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/polytherics-macrogenics-extend-deal-to-develop-new-antibody-drug-conjugates-140414-4214314/ 2014-04-14T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-rad-completes-acquisition-of-gnubio-140414-4214338/ 2014-04-14T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-presents-first-set-of-results-on-phase-iii-clinical-study-of-dysport-140414-4214272/ 2014-04-14T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/trinidad-tobago-ministry-of-health-approves-janssens-prostate-cancer-drug-zytiga-140414-4214346/ 2014-04-14T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-files-nda-to-fda-for-combination-tablet-to-treat-hiv-1-150414-4214459/ 2014-04-15T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-announces-notice-of-allowance-for-two-patent-applications-in-japan-150414-4214577/ 2014-04-15T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-announces-settlements-with-two-gralise-anda-filers-150414-4214586/ 2014-04-15T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mast-therapeutics-announces-new-data-supporting-mst-188-in-sickle-cell-disease-150414-4214662/ 2014-04-15T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/surrey-clinical-research-centre-signs-five-year-agreement-for-omnicomm-systems-promasys-150414-4214670/ 2014-04-15T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/protrials-completes-significant-phase-iii-clinical-trial-for-new-ophthalmic-disease-treatment-150414-4214682/ 2014-04-15T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/intellicell-biosciences-selects-inventiv-health-clinical-as-cro-for-osteoarthritis-ind-150414-4214713/ 2014-04-15T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-to-acquire-global-rights-of-bupivacaine-from-oracain-150414-4215043/ 2014-04-15T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bmv-medica-to-distribute-eastons-viorra-in-mexico-150414-4215046/ 2014-04-15T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-nda-for-combination-drug-to-treat-type-2-diabetes-150414-4215055/ 2014-04-15T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-extends-market-exclusivity-of-biomarins-phenylketonuria-drug-kuvan-for-six-months-150414-4215058/ 2014-04-15T09:04:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithklines-tanzeum-gets-fda-approval-for-type-2-diabetes-treatment-160414-4215125/ 2014-04-15T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-announces-agreement-related-to-generess-fe-patent-challenge-litigation-160414-4215454/ 2014-04-16T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/panoptica-raises-45m-to-finance-clinical-development-of-anti-vegf-eye-drop-for-wet-amd-160414-4215489/ 2014-04-16T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-launches-probi-digestis-in-korea-160414-4215509/ 2014-04-16T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/kineta-and-rlb-holdings-announce-new-joint-venture-160414-4215551/ 2014-04-16T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/akebia-therapeutics-completes-enrollment-in-its-phase-iib-clinical-study-of-akb-6548-160414-4215578/ 2014-04-16T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/medac-pharma-gets-fda-approval-for-trade-name-rasuvo-for-injectable-mtx-product-160414-4215922/ 2014-04-16T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/prosonix-mylan-license-agreement-for-generic-versions-of-flixotide-and-flovent-160414-4215853/ 2014-04-16T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/raintree-launches-new-cloud-based-analytics-portal-for-pharmaceutical-industry-160414-4215651/ 2014-04-16T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/prestige-to-acquire-otc-oral-rehydration-product-hydralyte-in-australia-160414-4215926/ 2014-04-16T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/designmedix-gets-3m-nih-grant-to-develop-low-cost-malaria-drug-160414-4215927/ 2014-04-16T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-begins-phase-i-trial-of-dcr-myc-to-treat-solid-tumors-hematological-malignancies-170414-4216027/ 2014-04-16T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-realigns-discovery-and-development-services-to-support-customer-demand-170414-4216265/ 2014-04-17T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/european-medicines-agency-alerts-eu-healthcare-professionals-after-vials-of-falsified-herceptin-identified-170414-4216275/ 2014-04-17T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-reaches-agreement-with-us-department-of-justice-170414-4216280/ 2014-04-17T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-biosciences-uk-partner-accepts-first-shipment-of-vitaros-170414-4216286/ 2014-04-17T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/iconic-therapeutics-raises-20m-to-advance-clinical-development-of-wet-amd-program-170414-4216294/ 2014-04-17T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-msd-launch-suglat-tablets-in-japan-to-treat-type-2-diabetes-170414-4216508/ 2014-04-17T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/oxthera-secures-10m-investment-to-continue-clinical-programs-170414-4216647/ 2014-04-17T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-begins-phase-iii-trial-of-asthma-drug-benralizumab-in-japan-170414-4216612/ 2014-04-17T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-sciences-reports-results-from-two-phase-iib-clinical-studies-for-type-2-diabetics-drug-170414-4216413/ 2014-04-17T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-introduces-renvela-for-patients-with-chronic-kidney-disease-170414-4216715/ 2014-04-17T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-european-commission-grant-orphan-drug-status-to-boehringers-volasertib-170414-4216719/ 2014-04-18T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-obtains-canadian-approval-for-incruse-ellipta-210414-4216819/ 2014-04-20T23:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ventirx-pharmaceuticals-completes-patient-enrollment-in-phase-ii-gog-3003-study-210414-4216948/ 2014-04-21T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/akorn-closes-hi-tech-pharmacals-acquisition-210414-4216984/ 2014-04-21T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-pharmaceuticals-begins-phase-i-study-of-pyruvate-kinase-deficiency-drug-210414-4217024/ 2014-04-21T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-pharmaceuticals-initiates-voluntary-recall-of-cubicin-intravenous-injection-210414-4217095/ 2014-04-21T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/coldstream-laboratories-completes-successful-fda-inspection-210414-4218023/ 2014-04-21T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-announces-termination-of-mogamulizumab-licensing-agreement-with-amgen-210414-4218086/ 2014-04-21T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/multicorp-engages-two-firms-to-develop-clinical-trial-procedures-on-patented-migraine-medicine-210414-4217273/ 2014-04-21T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-receives-orphan-drug-designation-for-volasertib-in-us-and-eu-210414-4217240/ 2014-04-21T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-announces-phase-iii-study-results-in-lancet-oncology-210414-4217293/ 2014-04-21T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/nanovalent-nanosmart-to-develop-enhanced-cancer-pharmaceuticals-210414-4217306/ 2014-04-21T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/alcresta-announces-agreement-with-cfft-to-develop-point-of-care-nutritional-products-210414-4217414/ 2014-04-21T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lillys-cyramza-to-treat-advanced-gastric-cancer-220414-4217640/ 2014-04-21T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/foamix-announces-issuance-of-five-additional-us-patents-220414-4218035/ 2014-04-22T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/enzymotec-announces-final-decision-issued-by-uspto-rejecting-all-claims-in-neptunes-patent-220414-4218048/ 2014-04-22T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biocisions-temperature-standardization-technology-to-be-used-in-txcell-phase-iib-cell-therapy-clinical-trial-220414-4218063/ 2014-04-22T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pronai-therapeutics-raises-595m-series-d-financing-220414-4218074/ 2014-04-22T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ctca-selects-medline-as-prime-vendor-distribution-partner-for-medical-and-surgical-supplies-220414-4218105/ 2014-04-22T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-seeks-fda-approval-for-new-antibiotic-to-treat-cuti-and-ciai-220414-4218124/ 2014-04-22T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-gets-notice-of-allowance-for-us-patent-for-treatment-of-stroke-using-t4-220414-4218069/ 2014-04-22T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reshapes-business-by-signing-deals-with-gsk-eli-lilly-220414-4218360/ 2014-04-22T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-reintroduces-adenosine-injection-with-improved-prefilled-plastic-syringes-220414-4218413/ 2014-04-22T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-exercises-option-with-amunix-to-develop-xtenylated-factor-viii-products-220414-4218477/ 2014-04-22T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-emergents-anthrax-vaccine-biothrax-220414-4218480/ 2014-04-22T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-theravance-start-phase-iii-trial-of-fluticasone-furoatevilanterol-to-treat-copd-230414-4218635/ 2014-04-22T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-ackman-sign-deal-to-acquire-botox-maker-allergan-for-45bn-230414-4218796/ 2014-04-23T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-may-push-ahead-with-second-approach-for-astrazenecas-deal-230414-4218813/ 2014-04-23T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biodel-announces-collaboration-agreement-with-hec-pharm-230414-4219211/ 2014-04-23T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-ciprofloxacin-dpi-gets-fda-orphan-drug-designation-230414-4219200/ 2014-04-23T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/vascular-solutions-enters-into-agreement-with-us-army-to-develop-freeze-dried-plasma-product-230414-4219230/ 2014-04-23T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-pharmaceuticals-granted-new-patent-for-abuse-deterrent-technology-230414-4219269/ 2014-04-23T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/epistem-announces-further-partnership-with-the-university-of-manchester-230414-4219284/ 2014-04-23T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/prolynx-gets-us-patent-covering-controlled-drug-release-from-dendrimer-conjugates-230414-4219309/ 2014-04-23T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-submits-nda-to-fda-for-hepatitis-c-drug-230414-4219488/ 2014-04-23T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-samsung-biologics-expand-drug-manufacturing-agreement-230414-4219369/ 2014-04-23T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-and-russias-ural-federal-university-sign-license-agreement-for-pure-230414-4219247/ 2014-04-23T10:21:00+00:00 https://www.pharmaceutical-business-review.com/news/janssens-mcd-drug-sylvant-gets-fda-approval-240414-4219680/ 2014-04-23T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/frutarom-health-launches-new-phytopharmaceutical-ingredients-line-240414-4219893/ 2014-04-24T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/alphaeon-to-launch-interactive-platform-in-ophthalmology-240414-4219907/ 2014-04-24T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/bettrlife-partners-with-viridian-health-management-to-improve-diabetes-care-and-prevention-240414-4219926/ 2014-04-24T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-inks-strategic-joint-venture-agreement-with-yoshindo-240414-4219943/ 2014-04-24T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/vistagen-receives-notice-of-allowance-for-us-patent-expanding-stem-cell-technology-platform-240414-4220010/ 2014-04-24T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-oncofusion-sign-license-deal-for-new-bromodomain-proteins-in-oncology-240414-4220030/ 2014-04-24T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/catalyst-starts-process-to-offer-firdapse-at-no-cost-to-lems-patients-in-us-240414-4220046/ 2014-04-24T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/hemoshear-medivir-enter-research-and-development-collaboration-240414-4220110/ 2014-04-24T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvo-ferndale-partner-to-develop-two-topical-dermatology-products-240414-4220160/ 2014-04-24T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/bioheart-initiates-clinical-trial-of-adipocell-to-treat-copd-240414-4220480/ 2014-04-24T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/alexions-soliris-gets-orphan-drug-status-in-europe-for-organ-transplantation-240414-4220484/ 2014-04-24T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-hydra-biosciences-to-develop-small-molecule-inhibitors-to-treat-cns-disorders-250414-4220536/ 2014-04-24T23:03:00+00:00 https://www.pharmaceutical-business-review.com/news/theraclone-sciences-announces-identification-of-new-vulnerable-site-on-hiv-using-antibodies-discovered-with-i-star-technology-250414-4220710/ 2014-04-25T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/american-cryostem-announces-breakthroughs-in-expansion-and-lineage-specific-differentiations-of-adscs-250414-4220853/ 2014-04-25T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/cook-medical-to-introduce-stemulate-human-platelet-lysate-cell-culture-media-supplement-250414-4220856/ 2014-04-25T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ibio-receives-patent-allowance-in-china-for-fusion-protein-compositions-and-technology-250414-4220861/ 2014-04-25T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/alphaeon-expands-partnership-with-teoxane-laboratories-250414-4220863/ 2014-04-25T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-biogen-idec-enter-clinical-development-collaboration-250414-4220949/ 2014-04-25T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-enters-into-celebrex-patent-challenge-settlement-with-pfizer-250414-4220905/ 2014-04-25T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/agendia-daiichi-sankyo-collaborate-on-oncology-drug-development-250414-4221042/ 2014-04-25T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-nogra-pharma-sign-licence-deal-to-develop-ged-0301-for-crohns-disease-250414-4221251/ 2014-04-25T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/durata-begins-patient-enrollment-in-phase-iiib-trial-of-dalvance-to-treat-absssi-250414-4221273/ 2014-04-25T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/neptune-secures-new-us-patent-relating-to-treatment-of-alzheimers-disease-250414-4221287/ 2014-04-25T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-panel-recommends-boehringers-pradaxa-for-dvt-pe-treatment-280414-4253295/ 2014-04-27T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-selected-as-recipient-of-supplemental-government-subsidy-in-japan-280414-4253550/ 2014-04-28T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/neptune-and-enzymotec-conclude-final-patent-infringement-settlement-and-license-agreement-280414-4253560/ 2014-04-28T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/novozymes-to-open-new-research-and-development-center-in-us-280414-4253572/ 2014-04-28T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-challenges-fda-ruling-on-exclusivity-relating-to-celecoxib-280414-4253582/ 2014-04-28T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/tb-alliance-says-new-tuberculosis-drug-regimen-will-move-to-phase-3-clinical-trial-280414-4253588/ 2014-04-28T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-instead-trial-of-onbrez-breezhaler-in-copd-patients-meets-primary-objective-280414-4253711/ 2014-04-28T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-marketing-approval-to-gsks-diabetes-drug-based-on-novozymes-veltis-technology-280414-4254088/ 2014-04-28T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/snbl-to-promote-crown-bioscience-services-to-japanese-clients-280414-4254117/ 2014-04-28T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-marketing-of-gsks-mekinist-to-treat-metastatic-melanoma-280414-4254129/ 2014-04-28T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-approval-of-sorafenib-in-eu-to-treat-differentiated-thyroid-cancer-280414-4254150/ 2014-04-28T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/genervon-completes-phase-iia-trial-of-als-drug-candidate-gm604-280414-4254161/ 2014-04-28T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-gets-eu-marketing-authorization-for-copd-treatment-incruse-290414-4254302/ 2014-04-28T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-uk-aims-to-increase-funding-into-cancer-research-290414-4254522/ 2014-04-29T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/diaxonhit-receives-financing-from-bpifrance-to-develop-companion-diagnostic-for-therapeutic-vaccine-against-aids-290414-4254633/ 2014-04-29T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-enters-into-agreement-with-intravacc-to-develop-sabin-inactivated-polio-vaccine-290414-4254772/ 2014-04-29T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-biopharma-announces-department-of-defense-grant-for-neuvax-clinical-trial-290414-4254788/ 2014-04-29T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/dod-recommends-funding-for-neumedicines-phase-i-study-of-recombinant-human-interleukin-12-290414-4254803/ 2014-04-29T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-gets-eu-approval-for-roactemra-to-treat-rheumatoid-arthritis-290414-4254930/ 2014-04-29T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-takeda-partner-to-commercialize-rasagiline-in-japan-to-treat-parkinsons-disease-290414-4255016/ 2014-04-29T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/agenus-merck-partner-to-develop-new-cancer-treatments-290414-4255132/ 2014-04-29T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pierre-fabre-opts-for-qumas-doccompliance-to-manage-quality-documents-290414-4255155/ 2014-04-29T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-files-petitions-south-africa-department-of-health-for-license-to-conduct-cannabis-research-290414-4255177/ 2014-04-29T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/sta-to-distribute-alimeras-iluvien-in-australia-and-new-zealand-290414-4255194/ 2014-04-29T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/integrity-cornerstone-merge-to-form-new-company-300414-4255219/ 2014-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/regenx-aavlife-enter-license-deal-to-develop-new-treatments-for-friedreichs-ataxia-300414-4255250/ 2014-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ohr-closes-patient-enrollment-in-phase-ii-trial-of-wet-amd-treatment-squalamine-300414-4255252/ 2014-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-sues-fda-regarding-delay-in-approval-of-generic-celebrex-300414-4255254/ 2014-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-to-acquire-furiex-pharmaceuticals-for-11bn-300414-4255257/ 2014-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravances-anoro-ellipta-intoduced-in-us-for-copd-treatment-300414-4255259/ 2014-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gallus-enters-cell-line-optimization-manufacturing-deal-with-omni-bio-pharmaceutical-300414-4255262/ 2014-04-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sturge-weber-foundation-awards-research-grants-to-advance-treatment-of-sturge-weber-syndrome-300414-4256100/ 2014-04-30T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/circulomics-awarded-phase-i-sbir-to-develop-nanobind-dna-extraction-technology-300414-4256116/ 2014-04-30T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/flexion-begins-phase-iib-trial-of-pain-drug-compound-fx006-to-treat-osteoarthritis-010514-4255423/ 2014-04-30T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/kempharm-receives-notice-of-allowance-for-prodrug-of-hydromorphone-010514-4256134/ 2014-05-01T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-partner-gsk-gains-priority-review-designation-for-promactarevolade-010514-4256147/ 2014-05-01T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/aceto-completes-acquisition-of-pack-pharmaceuticals-010514-4256158/ 2014-05-01T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/medpace-reference-laboratories-opens-central-laboratory-in-singapore-010514-4256166/ 2014-05-01T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gsks-incruse-ellipta-to-treat-airflow-obstruction-in-copd-patients-010514-4256177/ 2014-05-01T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-cleveland-clinic-enter-into-multiple-sclerosis-research-collaboration-010514-4256199/ 2014-05-01T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/oricula-therapeutics-secures-nih-grant-to-further-develop-medicine-to-preserve-hearing-010514-4256219/ 2014-05-01T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-mediwiet-to-conduct-clinical-observational-study-in-netherlands-010514-4256555/ 2014-05-01T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-regains-commercialization-rights-of-egrifta-in-canada-010514-4256572/ 2014-05-01T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-launches-adasuve-in-the-nordic-countries-010514-4256579/ 2014-05-01T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-announces-positive-opinion-from-irish-medicines-board-for-botox-020514-4256662/ 2014-05-01T22:41:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-receives-orphan-drug-designation-from-fda-for-cervical-cancer-drug-020514-4256770/ 2014-05-02T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/nova-laboratories-receives-fda-approval-for-acute-lymphoblastic-leukemia-drug-020514-4256832/ 2014-05-02T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/complexa-initiates-first-human-clinical-trial-of-cxa-10-in-acute-kidney-injury-020514-4256963/ 2014-05-02T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/trevena-begins-phase-ii-study-of-trv130-in-acute-postoperative-pain-020514-4257071/ 2014-05-02T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/palatin-technologies-announces-option-exercise-by-pharmaceutical-firm-to-license-bremelanotide-in-europe-020514-4257194/ 2014-05-02T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/parion-sciences-receives-fda-acceptance-of-ind-application-for-p-321-ophthalmic-solution-020514-4257210/ 2014-05-02T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-pharma-announces-mm-398-achieves-primary-endpoint-in-phase-iii-study-020514-4257243/ 2014-05-02T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/alcobra-issued-new-us-patent-covering-metadoxine-use-for-cognitive-disorders-020514-4257268/ 2014-05-02T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharma-sofgen-pharma-sign-agreement-to-develop-anda-soft-gel-oral-drug-product-020514-4257153/ 2014-05-02T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-announces-us-patent-issuance-covering-cudc-907-composition-of-matter-020514-4257300/ 2014-05-02T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/loxo-oncology-begins-phase-i-study-of-trk-inhibitor-050214-4257172/ 2014-05-02T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ruthigen-submits-ind-application-to-fda-for-phase-iii-clinical-trial-of-rut58-60-050514-4257773/ 2014-05-04T23:35:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-enrolls-first-patient-in-phase-iii-study-of-rviii-singlechain-050514-4257818/ 2014-05-05T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/second-genome-pfizer-sign-agreement-for-microbiome-research-in-obesity-050514-4257866/ 2014-05-05T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cystinosis-research-foundation-raises-23m-for-research-to-treat-and-cure-cystinosis-050514-4259157/ 2014-05-05T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/greer-laboratories-launches-oralair-to-treat-grass-pollen-allergy-050514-4259174/ 2014-05-05T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-orphan-drug-designation-to-oncomeds-pancreatic-cancer-drug-050514-4257998/ 2014-05-05T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/novogen-announces-collaboration-with-genea-biocells-for-testing-of-super-benzopyran-drugs-050514-4258034/ 2014-05-05T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/covagen-begins-phase-ibiia-study-of-anti-tnfil-17a-fynomab-cova322-4258207/ 2014-05-05T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-presents-phase-iii-trial-data-of-signifor-lar-050514-4258296/ 2014-05-05T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-complete-response-letter-for-plumiaz-050514-4258325/ 2014-05-05T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/dsmb-recommends-stopping-vintafolide-proceed-phase-iii-trial-050514-4258360/ 2014-05-05T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/auven-therapeutics-bellus-health-announce-license-agreement-with-mount-sinai-for-kiacta-in-sarcoidosis-050514-4258371/ 2014-05-05T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-avalanche-to-develop-new-gene-therapy-products-in-ophthalmology-060514-4258979/ 2014-05-05T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/kinex-receives-fda-allowance-for-oratecan-060514-4259113/ 2014-05-06T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/forma-therapeutics-acquires-covalent-chemistry-platform-from-netherlands-cancer-institute-060514-4259138/ 2014-05-06T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-signs-material-transfer-agreement-with-wageningen-university-for-niagen-research-060514-4259209/ 2014-05-06T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/nanoantibiotics-to-begin-trading-on-otc-markets-060514-4259226/ 2014-05-06T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-lundbeck-announce-availability-of-abilify-maintena-in-canada-060514-4259240/ 2014-05-06T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/tevas-synribo-for-injection-gets-fda-approval-for-home-administration-to-treat-cml-060514-4260030/ 2014-05-06T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-gets-mjff-grant-for-biological-markers-identification-in-parkinsons-disease-060514-4260036/ 2014-05-06T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/forma-enters-into-license-deal-with-nki-for-covalent-chemistry-platform-060514-4260059/ 2014-05-06T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cyclacel-gets-two-new-japanese-patents-for-sapacitabine-060514-4260060/ 2014-05-06T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/udg-healthcare-to-commercialize-cardiomes-brinavess-in-ireland-060514-4260068/ 2014-05-06T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cytovance-to-offer-manufacturing-services-for-selexys-selk2-antibody-070514-4263939/ 2014-05-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-astrazenecas-hypertriglyceridaemia-drug-epanova-070514-4260232/ 2014-05-06T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/3m-drug-delivery-systems-announces-expansion-of-mdi-facility-in-uk-070514-4260567/ 2014-05-07T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-advances-development-candidate-for-aln-aat-070514-4260576/ 2014-05-07T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/biologics-to-be-exclusive-specialty-pharmacy-provider-of-eli-lillys-cyramza-070514-4260598/ 2014-05-07T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-signs-agreement-with-patheon-to-manufacture-bti-320-tablets-070514-4260614/ 2014-05-07T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-genomics-signs-collaborative-rd-agreement-with-lung-biotechnology-070514-4260627/ 2014-05-07T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-snda-for-astellas-medivations-prostate-cancer-drug-xtandi-070514-4260788/ 2014-05-07T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-gloria-partner-to-accelerate-development-of-cets-new-product-candidates-070514-4260828/ 2014-05-07T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-eternygen-to-discover-and-develop-new-metabolic-disease-therapy-070514-4260851/ 2014-05-07T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-enter-into-process-development-manufacturing-deal-with-macrogenics-070514-4260916/ 2014-05-07T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-sell-consumer-care-business-to-bayer-for-142bn-070514-4261165/ 2014-05-07T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-to-start-phase-iiiii-trial-of-dravet-syndrome-drug-epidiolex-in-h2-2014-080514-4261584/ 2014-05-07T23:09:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-to-develop-new-cancer-drugs-using-amgen-xenomouse-immunogen-technology-080514-4261737/ 2014-05-07T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/new-cervarix-two-dose-data-demonstrate-potential-for-increased-flexibility-of-vaccine-administration-schedule-080514-4262136/ 2014-05-08T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-and-vis-research-expand-research-site-group-to-help-streamline-pediatric-clinical-trials-080514-4262144/ 2014-05-08T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-receives-patent-in-eu-for-treatment-of-liver-function-following-surgery-080514-4262148/ 2014-05-08T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-xolair-for-treatment-of-chronic-hives-080514-4262167/ 2014-05-08T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/discovery-labs-expands-exclusivity-portfolio-with-three-new-us-patents-080514-4262181/ 2014-05-08T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-yale-to-develop-mif-inhibitors-to-treat-autoimmune-inflammatory-diseases-080514-4262248/ 2014-05-08T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/grnenthal-enters-into-distribution-agreement-with-msd-for-etoricoxib-in-europe-080514-4262570/ 2014-05-08T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/pivotal-therapeutics-gets-us-patent-8715648-for-vascazen-080514-4262666/ 2014-05-08T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/capricor-cedars-sinai-partner-for-exosome-related-ip-portfolio-080514-4262713/ 2014-05-08T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-starts-pediatric-mll-r-phase-ib-trial-of-epz-5676-080514-4262731/ 2014-05-08T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-alcobras-protocol-for-phase-iib-study-of-metadoxine-drug-candidate-090514-4262995/ 2014-05-09T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-announces-results-from-final-analysis-of-galaxy-1-trial-of-ganetespib-in-nsclc-090514-4263373/ 2014-05-09T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-announces-expanded-collaboration-with-international-partnership-for-microbicides-090514-4263383/ 2014-05-09T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-pharmaceuticals-announces-settlement-of-patent-litigation-with-ranbaxy-090514-4263389/ 2014-05-09T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ds-healthcare-files-us-patent-on-new-compound-for-hair-loss-090514-4263396/ 2014-05-09T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-initiates-phase-iii-trial-of-medi4736-to-treat-nsclc-patients-090514-4263445/ 2014-05-09T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-strengthens-c-difficile-program-with-new-patents-in-europe-090514-4263650/ 2014-05-09T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/aicuris-merck-announce-publication-of-phase-ii-study-results-for-letermovir-in-new-england-journal-of-medicine-090514-4263950/ 2014-05-09T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/nymox-announces-completion-of-second-phase-iii-nx-1207-trial-for-bph-090514-4263956/ 2014-05-09T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-pharmatech-starts-construction-of-new-rd-cgmp-manufacturing-site-in-china-090514-4263779/ 2014-05-09T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/otonomy-closes-patient-enrollment-in-auripro-phase-iii-clinical-trials-090514-4263835/ 2014-05-09T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-gets-approval-for-copd-drug-anoro-in-europe-090514-4263874/ 2014-05-09T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-files-maa-in-eu-for-interferon-free-hepatitis-c-therapy-090514-4263933/ 2014-05-09T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-astrazeneca-report-positive-results-in-phase-iii-trial-of-psoriasis-drug-brodalumab-120514-4264163/ 2014-05-11T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/chpa-files-comments-to-fda-regarding-otc-monograph-system-120514-4264497/ 2014-05-12T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-increases-ownership-stake-in-nantpro-biosciences-120514-4264502/ 2014-05-12T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/new-colombia-resources-enters-into-collaboration-agreement-with-phoenix-tears-foundation-120514-4264514/ 2014-05-12T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm-and-lees-pharmaceutical-announce-execution-of-two-collaboration-agreements-120514-4264529/ 2014-05-12T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ohr-pharma-initiates-investigator-sponsored-trial-of-squalamine-eye-drops-in-diabetic-macular-edema-120514-4264545/ 2014-05-12T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-releases-positive-phase-ii-trial-results-of-meningococcal-b-vaccine-120514-4264562/ 2014-05-12T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ajanta-pharma-launches-risperidone-tablets-120514-4264587/ 2014-05-12T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-opens-new-biotechnology-manufacturing-facility-in-australia-120514-4264679/ 2014-05-12T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-to-study-development-of-cannabis-based-cancer-treatments-120514-4264704/ 2014-05-12T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-prima-biomeds-cvac-120514-4264734/ 2014-05-12T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/omni-bio-announces-grant-of-new-use-patent-in-europe-120514-4264859/ 2014-05-12T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/kythera-files-nda-for-atx-101-to-reduce-unwanted-submental-fat-130514-4265243/ 2014-05-13T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-announces-launch-of-fycompa-in-netherlands-130514-4265421/ 2014-05-13T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/vida-canada-files-licensed-commercial-producer-application-with-health-canada-130514-4265432/ 2014-05-13T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/mabvax-therapeutics-and-telik-sign-definitive-merger-agreement-130514-4265439/ 2014-05-13T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-biopharma-announces-issuance-of-notice-of-allowance-for-patent-application-covering-adva-27a-in-canada-130514-4265451/ 2014-05-13T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/berg-medical-university-of-south-carolina-collaborate-to-identify-lupus-biomarkers-130514-4265817/ 2014-05-13T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/taxus-cardiums-excellagen-selected-for-use-with-stem-cells-in-eu-funded-human-clinical-study-130514-4265398/ 2014-05-13T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/antriabio-establishes-new-manufacturing-laboratory-facility-in-colorado-us-130514-4266083/ 2014-05-13T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-enters-into-patent-settlement-agreements-with-valeant-for-acanya-gel-tiazac-xc-130514-4266106/ 2014-05-13T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-gets-fda-approval-for-generic-version-of-astepro-nasal-spray-130514-4266160/ 2014-05-13T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-seoul-national-university-collaborate-on-new-research-center-130514-4266165/ 2014-05-13T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-orion-enter-into-drug-discovery-program-in-pain-management-area-140514-4267232/ 2014-05-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-fda-approval-for-invega-sustenna-to-treat-schizoaffective-disorder-140514-4266335/ 2014-05-13T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-announces-agreement-to-acquire-encore-health-resources-140514-4266700/ 2014-05-14T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-pharmaceuticals-acquires-early-stage-dna-therapies-to-treat-alzheimers-and-multiple-sclerosis-140514-4266711/ 2014-05-14T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-board-unanimously-rejects-unsolicited-proposal-from-valeant-140514-4266715/ 2014-05-14T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-resubmits-fycompa-to-german-federal-joint-committee-for-additional-benefit-assessment-140514-4266723/ 2014-05-14T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/tribute-pharma-faes-farma-announce-exclusive-license-agreement-in-canada-for-bilastine-140514-4266730/ 2014-05-14T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/neostem-announces-licensing-agreement-to-begin-phase-ii-hepatocellular-carcinoma-trial-in-china-140514-4266743/ 2014-05-14T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-gets-final-fda-approval-for-generic-version-of-pain-drug-exalgo-140514-4267097/ 2014-05-14T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/dbv-technologies-to-develop-viaskin-milk-for-eosinophilic-esophagitis-treatment-140514-4267175/ 2014-05-14T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-to-buy-mercks-ophthalmology-products-140514-4267204/ 2014-05-14T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-files-expanded-label-indication-for-zestra-to-health-canada-140514-4267274/ 2014-05-14T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/amakem-initiates-phase-ii-trial-of-ama0076-for-glaucoma-treatment-140514-4267285/ 2014-05-14T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-healthcare-opens-new-research-incubator-colaborator-in-berlin-150514-4268441/ 2014-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/questcor-enters-into-development-agreement-for-new-melanocortin-peptides-150514-4268465/ 2014-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-signs-research-licensing-deal-with-omthera-for-new-dyslipidemia-treatment-150514-4268475/ 2014-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-files-clinical-trial-application-for-l-dos47-in-canada-to-treat-solid-tumors-150514-4268486/ 2014-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novozymes-to-provide-drug-albumin-conjugation-platform-in-collaboration-with-thiologics-150514-4268498/ 2014-05-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-incyte-enter-clinical-trial-collaboration-for-new-cancer-treatment-150514-4267523/ 2014-05-14T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-therapeutics-to-acquire-us-rights-of-migraine-drug-treximet-from-gsk-150514-4268022/ 2014-05-15T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-celldex-enter-clinical-trial-collaboration-to-evaluate-nivolumab-varlilumab-combination-150514-4268096/ 2014-05-15T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-fda-to-facilitate-clinical-investigation-of-new-medicines-for-gaucher-disease-in-children-150514-4268106/ 2014-05-15T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-biopharma-to-study-alferon-against-tamiflu-resistant-influenza-virus-strains-150514-4268124/ 2014-05-15T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/biolight-gets-us-patent-approval-for-latanoprost-to-treat-glaucoma-150514-4268221/ 2014-05-15T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-phase-iii-trial-of-darapladib-fails-to-meet-primary-endpoint-in-patients-following-acs-150514-4268254/ 2014-05-15T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/transition-doses-first-patient-in-phase-ii-trial-of-diabetes-drug-candidate-tt-401-160514-4268796/ 2014-05-15T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-and-mrc-laboratory-of-molecular-biology-to-launch-joint-research-fund-190514-4270482/ 2014-05-16T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/neos-therapeutics-gets-new-patent-for-amphetamine-adhd-products-160514-4269332/ 2014-05-16T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/brf-grant-expands-research-on-using-exercise-to-slow-the-path-to-alzheimers-and-dementia-160514-4269366/ 2014-05-16T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/oxthera-strengthens-patent-portfolio-for-hyperoxaluria-treatment-160514-4269391/ 2014-05-16T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/concordia-healthcare-completes-acquisition-of-donnatal-160514-4269411/ 2014-05-16T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ohr-pharmaceutical-agrees-to-acquire-technology-assets-of-sks-ocular-160514-4269443/ 2014-05-16T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-pharma-initiates-patient-enrollment-in-post-marketing-ejectdelay-clinical-trial-160514-4269618/ 2014-05-16T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-zyprexa-zydis-tablets-160514-4269486/ 2014-05-16T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/reckitt-xenoport-enter-into-licensing-deal-for-arbaclofen-placarbil-160514-4269759/ 2014-05-16T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-extends-concerta-distribution-agreement-with-janssen-160514-4269768/ 2014-05-16T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/portage-signs-rd-agreement-with-us-national-institute-of-health-160514-4269775/ 2014-05-16T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/tolmar-pharma-to-market-prostate-cancer-drug-eligard-in-us-puerto-rico-190514-4271263/ 2014-05-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-aska-sign-distribution-deal-for-hypertension-drug-candesartan-aska-190514-4269940/ 2014-05-18T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-discovery-to-acquire-combinatorx-service-business-and-assets-from-zalicus-190514-4270499/ 2014-05-19T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/kymab-secures-40m-investment-to-advance-clinical-development-of-antibody-therapeutics-190514-4270521/ 2014-05-19T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-opens-new-healthcare-distribution-center-in-malaysia-190514-4270550/ 2014-05-19T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-announces-expanded-access-program-for-pirfenidone-190514-4270597/ 2014-05-19T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ncku-professor-discovers-drug-to-inhibit-liver-cancer190514-4270624/ 2014-05-19T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/gelesis-discloses-recent-12m-funding-190514-4270654/ 2014-05-19T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/telormedixs-vesimune-completes-phase-ii-trial-for-cis-of-the-bladder-190514-4271048/ 2014-05-19T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-seeks-fda-approval-for-breast-cancer-drug-palbociclib-190514-4271140/ 2014-05-19T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-announces-eap-for-pirfenidone-to-treat-idiopathic-pulmonary-fibrosis-in-us-190514-4271172/ 2014-05-19T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-rejects-pfizers-final-takeover-bid-200514-4271506/ 2014-05-19T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/senesco-completes-acquisition-of-fabrus-200514-4272184/ 2014-05-20T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-completes-acquisition-of-rights-to-sumavel-dosepro-200514-4272196/ 2014-05-20T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/clovis-oncology-receives-breakthrough-therapy-designation-for-co-1686-200514-4272212/ 2014-05-20T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-pharma-antiop-enters-into-agreement-to-develop-naloxone-nasal-spray-for-opioid-overdose-200514-4272230/ 2014-05-20T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/ipf-phase-iii-results-published-in-nejm-show-nintedanib-slows-disease-progression-boehringer-ingelheim-200514-4272254/ 2014-05-20T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-signs-licensing-commercialization-deal-with-ophthotech-for-fovista-200514-4272518/ 2014-05-20T11:00:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-wipro-partners-to-enable-global-it-platform-200514-4272521/ 2014-05-20T11:00:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-gets-fda-fast-track-status-for-livatag-to-treat-primary-liver-cancer-200514-4272525/ 2014-05-20T11:00:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-abbvies-myeloma-drug-elotuzumab-gets-fda-breakthrough-therapy-status-200514-4272526/ 2014-05-20T11:00:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-gets-new-canadian-patent-for-zestra-200514-4272523/ 2014-05-20T11:01:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-genmabs-phase-iii-trial-of-lymphoma-treatment-fails-to-meet-primary-endpoint-200514-4272529/ 2014-05-20T11:09:00+00:00 https://www.pharmaceutical-business-review.com/news/takedas-entyvio-gets-fda-approval-to-treat-ulcerative-colitis-or-crohns-disease-210514-4272648/ 2014-05-20T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-receives-south-korean-clearance-to-use-plx-in-advances-studies-210514-4273022/ 2014-05-21T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/adamas-pharmaceuticals-receives-25m-milestone-payment-from-forest-laboratories-210514-4273029/ 2014-05-21T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ceapro-licenses-process-technology-from-university-of-alberta-210514-4273048/ 2014-05-21T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-signs-marketing-agreement-with-benchworks-sd-for-sugardown-210514-4273070/ 2014-05-21T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/medidata-and-transcelerate-biopharma-announce-joint-initiative-210514-4273173/ 2014-05-21T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-spend-50m-on-italian-production-facility-210514-4273572/ 2014-05-21T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiome-enters-into-commercialization-deal-with-aop-orphan-for-aggrastat-210514-4273605/ 2014-05-21T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-inventiv-health-partner-for-commercialization-of-zubsolv-in-us-210514-4273686/ 2014-05-21T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/aadi-celgene-ink-licensing-deal-for-nanotechnology-based-drug-candidate-210514-4273708/ 2014-05-21T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharm-secures-fda-orphan-drug-status-for-selinexor-to-treat-dlbcl-210514-4273761/ 2014-05-21T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/relypsa-dsm-fine-chemicals-enter-into-commercial-manufacturing-agreement-for-patiromer-210514-4273733/ 2014-05-21T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/clinverse-enters-into-strategic-partnership-with-eclinical-insights-220514-4275057/ 2014-05-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/inhibikase-secures-fda-orphan-drug-status-for-imatinib-to-treat-pml-220514-4274034/ 2014-05-21T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-td2-begin-preparations-for-us-based-studies-on-symptoms-associated-with-pancreatic-cancer-220514-4276633/ 2014-05-22T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-provides-us-regulatory-update-on-hyqvia-220514-4276640/ 2014-05-22T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-and-gp-pharm-agree-to-establish-manufacturing-operation-in-argentina-220514-4274416/ 2014-05-22T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/antiop-partners-with-reckitt-benckiser-to-develop-nasally-administered-treatment-for-opioid-overdose-220514-4274424/ 2014-05-22T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-launches-perceptive-mytrials-data-driven-monitoring-solution-220514-4274429/ 2014-05-22T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-pharmaceuticals-announces-settlement-of-patent-litigation-with-sandoz-220514-4274438/ 2014-05-22T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/discoverx-enables-predictive-in-vitro-drug-combination-studies-with-launch-of-biomap-combo-elect-220514-4274441/ 2014-05-22T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/sanford-burnham-daiichi-sankyo-to-develop-new-therapies-for-cardiovascular-metabolic-diseases-220514-4274916/ 2014-05-22T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/lanthio-pharma-gets-36m-dutch-loan-for-new-lung-fibrosis-therapy-220514-4274948/ 2014-05-22T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/mediwound-begins-phase-ii-trial-of-escharex-to-treat-chronic-wounds-220514-4275003/ 2014-05-22T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/neurotez-gca-therapeutics-to-develop-leptin-derivatives-to-treat-alzheimers-disease-in-china-220514-4275020/ 2014-05-22T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/sotio-begins-phase-iii-trial-of-dcvacpca-to-treat-prostate-cancer-230514-4275293/ 2014-05-22T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/nccn-receives-2m-in-research-funding-from-boehringer-ingelheim-to-study-volasertib-in-hematologic-malignancies-230514-4275563/ 2014-05-23T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/rxi-pharmaceuticals-granted-us-notice-of-allowance-covering-sd-rxrna-technology-platform-230514-4275618/ 2014-05-23T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/veloxis-gets-ema-positive-opinion-for-envarsus-to-treat-kidney-liver-transplant-patients-230514-4276021/ 2014-05-23T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-agrees-to-acquire-manufacturing-facility-in-massachusetts-us-230514-4276046/ 2014-05-23T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-files-nds-with-health-canada-for-investigational-regimen-to-treat-hepatitis-c-230514-4276122/ 2014-05-23T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/australias-tga-approves-protalixs-elelyso-for-injection-to-treat-gaucher-disease-230514-4276147/ 2014-05-23T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/emerson-ecologics-adds-prescription-and-injectable-therapies-to-product-portfolio-230514-4275610/ 2014-05-23T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/biorestorative-pfizer-enter-into-research-agreement-230514-4276206/ 2014-05-23T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-gets-fda-approval-to-start-phase-iii-trial-of-rhb-102-230514-4276208/ 2014-05-23T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/viking-signs-licensing-deal-with-ligand-pharma-for-rights-to-five-therapeutic-programs-230514-4275666/ 2014-05-23T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/durata-therapeutics-dalvance-injection-gets-fda-approval-260514-4276338/ 2014-05-25T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-could-abandon-70bn-take-over-bid-of-astrazeneca-260514-4276531/ 2014-05-26T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/diplomat-to-distribute-synribo-for-chronic-myeloid-leukemia-260514-4276792/ 2014-05-26T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/batu-biologics-files-patent-application-for-vallovax-260514-4276803/ 2014-05-26T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/prima-biomeds-cvac-patent-application-receives-us-notice-of-allowance-260514-4276822/ 2014-05-26T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ptc-therapeutics-receives-positive-opinion-from-chmp-for-translarna-260514-4276832/ 2014-05-26T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/supreme-pharma-acquires-ontario-greenhouse-complex-for-future-medical-marijuana-production-260514-4276847/ 2014-05-26T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-tevas-qvar-with-dose-counter-to-treat-asthma-260514-4276934/ 2014-05-26T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/emas-chmp-rejects-approval-of-multiple-sclerosis-drug-nerventra-260514-4276915/ 2014-05-26T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-phase-iii-trial-results-of-psoriasis-drug-tofacitinib-260514-4276738/ 2014-05-26T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-gets-positive-opinion-from-chmp-for-plegridy-multiple-sclerosis-injectable-260514-4276969/ 2014-05-26T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-gets-fda-approval-for-use-of-vectibix-plus-folfox-to-treat-colorectal-cancer-260514-4277006/ 2014-05-26T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-janssens-type-2-diabetes-drug-invokana-270514-4277203/ 2014-05-26T23:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-clearance-to-aztherapies-to-start-phase-iii-trial-of-ad-drug-alzt-op1-270514-4277540/ 2014-05-27T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-gets-ema-positive-opinion-for-nuwiq-to-treat-haemophilia-a-270514-4277688/ 2014-05-27T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/abiogen-lees-pharma-ink-marketing-deal-for-attila-270514-4278132/ 2014-05-27T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-complete-response-letter-regarding-qrxpharmas-moxduo-nda-270514-4278197/ 2014-05-27T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/orient-europharma-debiopharm-enter-distribution-deal-for-pamorelin-in-south-east-asia-270514-4278267/ 2014-05-27T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-canada-makes-tecfidera-available-for-reimbursement-in-ontario-270514-4278336/ 2014-05-27T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-cytomx-to-develop-probody-therapeutics-against-multiple-immuno-oncology-targets-270514-4278343/ 2014-05-27T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/mapi-pharma-gets-additional-claims-for-us-patent-of-glatiramer-acetate-depot-to-treat-multiple-sclerosis-270514-4278311/ 2014-05-27T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-inks-material-transfer-deals-with-leading-universities-for-defensin-mimetic-compounds-270514-4278318/ 2014-05-27T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-sells-back-rights-to-adc-1013-to-alligator-bioscience-270514-4278330/ 2014-05-27T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/macrogenics-takeda-to-develop-dart-to-treat-autoimmune-disorders-280514-4279542/ 2014-05-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-incyte-to-evaluate-combination-regimen-of-two-new-immunotherapies-for-multiple-cancers-280514-4279659/ 2014-05-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-genzymes-lemtrada-for-reimbursement-on-nhs-280514-4278507/ 2014-05-27T23:11:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-sell-skincare-products-to-nestle-for-14bn-280514-4279676/ 2014-05-27T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/solara-labs-introduces-barimelts-for-bariatric-surgery-patients-280514-4279141/ 2014-05-28T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-launches-otc-drug-nexium-24hr-for-heartburn-relief-280514-4279084/ 2014-05-28T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-confirms-anda-submission-for-generic-version-of-onglyza-280514-4279115/ 2014-05-28T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-secures-us-composition-of-matter-patent-covering-ampligen-formulations-280514-4279257/ 2014-05-28T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/stemedica-gets-ind-approval-from-indonesian-fda-to-initiate-phase-ii-trial-to-treat-ami-280514-4279283/ 2014-05-28T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/tekmira-begins-phase-iii-trial-of-tkm-plk1-to-treat-hepatocellular-carcinoma-280514-4279329/ 2014-05-28T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-designs-glaas-discovery-platform-used-in-medi7510-phase-i-trial-280514-4279396/ 2014-05-28T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/intensity-gets-crada-from-national-cancer-institute-290514-4280959/ 2014-05-28T13:55:00+00:00 https://www.pharmaceutical-business-review.com/news/rockwell-gets-fda-acceptance-for-filing-of-triferic-nda-290514-4280940/ 2014-05-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-lilly-ink-deal-for-non-prescription-erectile-dysfunction-drug-cialis-290514-4279868/ 2014-05-28T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-review-of-mallinckrodts-nda-for-pain-drug-candidate-mnk-155-290514-4280874/ 2014-05-28T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrocell-to-develop-manufacture-genetically-modified-cell-therapy-for-rdeb-treatment-290514-4280262/ 2014-05-29T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-pays-650m-to-settle-us-pradaxa-litigation-290514-4280285/ 2014-05-29T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-to-establish-anti-infectives-platform-with-euprotec-acquisition-290514-4280298/ 2014-05-29T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicomm-to-provide-trialmaster-edc-technology-to-undisclosed-cro-290514-4280345/ 2014-05-29T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/iroko-pharmaceuticals-secures-patent-for-tivorbex-290514-4280356/ 2014-05-29T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-trimels-natesto-nasal-gel-to-treat-men-with-low-testosterone-290514-4280598/ 2014-05-29T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/array-biopharma-biogen-idec-enter-drug-discovery-collaboration-290514-4280688/ 2014-05-29T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/effrx-pharma-signs-distribution-agreements-for-binosto-in-russia-africa-290514-4280814/ 2014-05-29T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/collegium-advances-hydrocodone-deterx-development-program-020614-4282327/ 2014-05-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-selects-inventiv-to-conduct-clinical-trials-for-new-immunotherapy-candidates-300514-4282245/ 2014-05-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novozymes-to-evaluate-new-subunit-vaccine-candidate-using-veltis-technology-300514-4282302/ 2014-05-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/adamis-files-nda-with-us-fda-for-epinephrine-pre-filled-syringe-300514-4281057/ 2014-05-29T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/aduro-janssen-enter-license-deal-for-new-immunotherapies-to-treat-prostate-cancer-300514-4281062/ 2014-05-29T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-vision-announces-positive-meeting-with-swedish-mpa-regarding-filing-for-marketing-approval-of-bromsite-300514-4281220/ 2014-05-30T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-pharma-completes-enrollment-in-phase-ii-trial-of-spi-2012-300514-4281230/ 2014-05-30T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-malarone-tablets-300514-4281253/ 2014-05-30T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/rodin-secures-129m-series-a-financing-to-develop-novel-treatments-for-cns-disorders-300514-4281273/ 2014-05-30T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/benitec-commences-patient-dosing-with-tt-034-in-patients-with-hepatitis-c-300514-4281781/ 2014-05-30T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-starts-phase-iib-trial-of-type-2-diabetes-drug-sugardown-300514-4281798/ 2014-05-30T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eisais-antiemetic-agent-aloxi-to-treat-children-300514-4281877/ 2014-05-30T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-phase-iii-trial-of-breast-cancer-combination-treatment-fails-to-meet-primary-endpoint-020614-4282083/ 2014-06-01T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamix-labs-opens-new-cgmp-supplement-manufacturing-facility-in-us-020614-4282581/ 2014-06-02T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-umn-seek-marketing-approval-for-flublok-influenza-vaccine-in-japan-020614-4282592/ 2014-06-02T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/enzo-biochem-innate-partner-to-validate-key-system-for-antibody-drug-conjugate-development-020614-4282692/ 2014-06-02T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sangamo-gets-cirm-fund-to-support-clinical-trial-of-zfp-therapeutic-for-hivaids-020614-4282711/ 2014-06-02T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/medinatura-agrees-to-acquire-heel-groups-us-operations-020614-4282731/ 2014-06-02T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/deciphera-begins-phase-i-cancer-trial-of-altiratinib-to-treat-solid-tumors-020614-4283051/ 2014-06-02T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-to-settle-patent-challenge-for-nuvigil-with-cephalon-020614-4282984/ 2014-06-02T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-gsk-to-start-studies-of-subcutaneous-ofatumumab-for-rrms-and-nmo-020614-4283025/ 2014-06-02T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-genzymes-lemtrada-resubmission-020614-4283043/ 2014-06-02T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/mediwound-grants-bexpharm-exclusive-marketing-rights-to-nexobrid-in-south-korea-020614-4283056/ 2014-06-02T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-reports-positive-preliminary-results-of-phase-iii-trial-of-melanoma-combination-immunotherapy-030614-4284043/ 2014-06-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/technovax-gets-nih-grant-to-develop-vlp-based-respiratory-syncytial-virus-vaccine-030614-4283714/ 2014-06-03T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-completes-acquisition-of-combinatorx-service-business-assets-from-zalicus-030614-4283734/ 2014-06-03T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-theravance-biopharma-complete-separation-into-two-drug-companies-030614-4283769/ 2014-06-03T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-recalls-certain-lots-of-soliris-concentrated-solution-for-intravenous-infusion-030614-4283790/ 2014-06-03T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-agrees-to-buy-oso-biopharmaceuticals-manufacturing-030614-4283798/ 2014-06-03T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-gsk-partner-to-develop-new-cancer-immunotherapies-030614-4283225/ 2014-06-03T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-phase-iii-trial-of-melanoma-drug-yervoy-meets-primary-endpoint-030614-4283829/ 2014-06-03T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/regenx-voyager-to-develop-new-therapies-for-multiple-cns-disorders-030614-4283858/ 2014-06-03T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-settles-patent-litigation-with-pfizer-on-generic-celebrex-capsules-030614-4283919/ 2014-06-03T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/itonis-gets-ndc-number-from-fda-enabling-marketing-of-otc-product-emesyl-030614-4283975/ 2014-06-03T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-closes-patient-enrollment-in-phase-i-trial-of-psoriasis-drug-prurisol-030614-4284159/ 2014-06-03T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-antibiotic-candidate-azd0914-gets-fda-fast-track-status-040614-4286278/ 2014-06-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-syngene-extend-research-collaboration-for-five-years-040614-4284397/ 2014-06-03T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/frontage-labs-plans-to-expand-chemistry-manufacturing-and-controls-facility-040614-4284986/ 2014-06-04T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/dermatology-cro-bioskin-joins-medrios-partner-program-040614-4285003/ 2014-06-04T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/foamix-national-institutes-of-health-to-develop-treatments-for-geographic-atrophy-040614-4285018/ 2014-06-04T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/aradigm-doses-first-patient-in-phase-iii-trial-of-ciprofloxacin-to-treat-non-cystic-fibrosis-bronchiectasis-040614-4285038/ 2014-06-04T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/trialscope-acquires-assets-of-deloitte-analytics-including-pharmacm-business-040614-4285051/ 2014-06-04T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/asana-acquires-branded-drug-discovery-platform-from-endo-pharmaceuticals-040614-4285191/ 2014-06-04T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-vandas-marketing-application-for-non-24-drug-hetlioz-040614-4285202/ 2014-06-04T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-gets-patent-rights-from-dartmouth-college-for-use-of-nicotinamide-riboside-040614-4285300/ 2014-06-04T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-grants-priority-review-to-hyperions-nds-for-ravicti-040614-4285337/ 2014-06-04T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-study-shows-zykadia-reduces-tumors-in-majority-of-alk-nsclc-patients-040614-4285361/ 2014-06-04T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/corepharma-launches-dextroamphetamine-sulfate-tablets-050614-4286603/ 2014-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kinemed-pfizer-renew-diabetes-research-collaboration-050614-4286606/ 2014-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-enters-research-collaboration-with-biotechnology-firm-for-technology-platforms-050614-4286612/ 2014-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-completes-patient-enrollment-in-phase-ii-extension-trial-ckd-drug-candidate-gcs-100-050614-4285550/ 2014-06-04T23:13:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-extends-rd-collaboration-with-hospices-civils-de-lyon-050614-4286266/ 2014-06-05T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/inventiv-health-aprecia-partner-to-commercialize-aprecias-technology-platform-050614-4286287/ 2014-06-05T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-vision-gets-notice-of-allowance-from-uspto-covering-bromfenac-formulations-in-durasite-050614-4286298/ 2014-06-05T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/trevi-therapeutics-gets-25m-series-b-financing-for-development-of-nalbuphine-er-050614-4286309/ 2014-06-05T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-opens-new-antibody-manufacturing-facility-in-switzerland-050614-4286321/ 2014-06-05T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/infosys-introduces-cloud-based-clinical-trial-supply-management-solution-050614-4286347/ 2014-06-05T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/argen-x-shire-pharma-enter-long-term-strategic-alliance-for-new-therapeutic-antibodies-050614-4286466/ 2014-06-05T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/paragon-phenylephrine-hydrochloride-ophthalmic-solution-now-available-via-bausch-lomb-050614-4286499/ 2014-06-05T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-begins-patient-enrollment-in-phase-iii-trial-of-hiv-drug-isentress-060614-4286744/ 2014-06-05T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-gets-fda-fast-track-status-for-epidiolex-to-treat-dravet-syndrome-060614-4287384/ 2014-06-06T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-lifts-drug-export-ban-on-ranbaxys-toansa-manufacturing-plant-060614-4287406/ 2014-06-06T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/molecularhealth-collaborates-with-sap-to-provide-new-employer-oncology-program-060614-4287430/ 2014-06-06T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/advanced-biological-laboratories-inks-research-licensing-agreement-with-lalrean-060614-4287447/ 2014-06-06T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/affiris-releases-phase-ii-trial-results-of-ad04-to-treat-alzheimers-disease-060614-4287505/ 2014-06-06T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-gets-decision-to-grant-japanese-patent-for-smarticles-nucleic-acid-delivery-technology-060614-4287525/ 2014-06-06T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-announces-new-rhb-104-patent-in-japan-060614-4287541/ 2014-06-06T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/gelstat-agrees-to-acquire-mastix-medica-060614-4287599/ 2014-06-06T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/momenta-secures-fda-orphan-drug-status-for-necuparanib-to-treat-pancreatic-cancer-060614-4287614/ 2014-06-06T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-to-pay-105m-in-asthma-antidepressant-drugs-settlement-060614-4287587/ 2014-06-06T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/revive-therapeutics-files-pre-ind-package-to-fda-for-gout-drug-candidate-rev-002-060614-4287619/ 2014-06-06T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/rentschler-expands-single-use-manufacturing-capacities-in-germany-090614-4288894/ 2014-06-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-pradaxa-secures-eu-approval-to-treat-dvt-pe-090614-4287705/ 2014-06-08T23:14:00+00:00 https://www.pharmaceutical-business-review.com/news/huntsman-cancer-institute-starts-new-105m-research-expansion-090614-4288271/ 2014-06-09T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/biodelivery-gets-fda-approval-for-bunavailto-treatment-opioid-dependence-090614-4288280/ 2014-06-09T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm-to-provide-api-to-taigen-for-new-stem-cell-drug-090614-4288295/ 2014-06-09T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-biogens-haemophilia-a-drug-eloctate-090614-4288472/ 2014-06-09T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-pharma-gets-patent-term-extension-for-ferumoxytol-injection-in-us-090614-4288493/ 2014-06-09T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-nih-enter-license-deal-for-tcr-based-products-for-multiple-cancer-indications-090614-4288523/ 2014-06-09T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/xeris-doses-first-patient-in-phase-ii-trial-of-soluble-glucagon-to-treat-hypoglycemia-090614-4288594/ 2014-06-09T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-reports-positive-phase-iii-trial-results-of-sivextro-090614-4288612/ 2014-06-09T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/galmed-files-provisional-patent-application-for-aramchol-to-treat-lipodystrophy-090614-4288623/ 2014-06-09T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-finalizes-asacol-hd-patent-challenge-litigation-with-zydus-pharma-100614-4289624/ 2014-06-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/acella-gets-fda-approval-for-hemophilia-treatment-tranexamic-acid-injection-100614-4288738/ 2014-06-09T23:18:00+00:00 https://www.pharmaceutical-business-review.com/news/edisons-epi-743-gets-fda-orphan-drug-status-for-leigh-syndrome-100614-4288864/ 2014-06-09T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-starts-multiple-ascending-dose-phase-i-trial-of-ag-348-to-treat-pk-deficiency-100614-4288837/ 2014-06-10T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-secures-us-patent-term-extension-for-tesamorelin-100614-4288971/ 2014-06-10T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-inks-deal-with-cellforcure-for-cgmp-manufacturing-of-allogeneic-cart-cells-100614-4288983/ 2014-06-10T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/batu-biologics-reports-development-plans-of-angiogenesis-targeting-cancer-vaccine-vallovax-100614-4289010/ 2014-06-10T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/tevas-azilect-gets-fda-approval-to-treat-all-stages-of-parkinsons-disease-100614-4289261/ 2014-06-10T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/valeants-onychomycosis-treatment-jublia-gets-fda-approval-100614-4289245/ 2014-06-10T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-agrees-to-buy-idenix-pharma-for-38bn-100614-4289421/ 2014-06-10T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/scripsamerica-signs-supply-deal-with-rapimed-manufacturer-100614-4289497/ 2014-06-10T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-paraplatin-injection-100614-4289723/ 2014-06-10T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-begins-two-phase-iii-trials-of-alks-5461-to-treat-major-depressive-disorder-110614-4289924/ 2014-06-10T23:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/synthetic-biologics-enterome-bioscience-partner-on-microbiome-research-110614-4290499/ 2014-06-11T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-reports-phase-iii-trial-results-of-lymphosee-to-treat-solid-tumors-110614-4290524/ 2014-06-11T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/paxvax-university-of-california-to-develop-new-vaccine-to-prevent-hsv-infections-110614-4290561/ 2014-06-11T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/novadigm-strengthens-candida-vaccine-portfolio-with-three-new-antigens-110614-4290568/ 2014-06-11T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-strengthens-livatag-patent-protection-in-japan-until-2032-4290575/ 2014-06-11T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/nordic-nanovector-betalutin-secures-orphan-designation-in-europe-for-lymphoma-treatment-110614-4290860/ 2014-06-11T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-gets-fda-clearance-for-ind-of-tnx-102-sl-in-post-traumatic-stress-disorder-110614-4290876/ 2014-06-11T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/synergy-research-uses-projecis-cloud-based-platform-to-manage-clinical-trials-110614-4290883/ 2014-06-11T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-vision-senju-to-develop-market-azithromycin-ophthalmic-solution-in-japan-110614-4290889/ 2014-06-11T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/protein-sciences-adds-distributor-for-flublok-recombinant-influenza-vaccine-110614-4290892/ 2014-06-11T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-astrazeneca-report-phase-ii-trial-results-of-psoriatic-arthritis-treatment-brodalumab-120614-4291025/ 2014-06-11T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/x-chem-pfizer-to-develop-new-treatments-for-inflammatory-orphan-diseases-120614-4291630/ 2014-06-12T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/cssi-establishes-new-lifesciences-division-120614-4291648/ 2014-06-12T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-announces-issuance-of-three-new-us-patents-for-cat-1000-series-120614-4291707/ 2014-06-12T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/bioxcel-expands-pharmgps-platform-for-design-of-orphan-disease-treatments-120614-4291722/ 2014-06-12T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/endonovo-to-develop-next-generation-cell-free-regenerative-products-120614-4291859/ 2014-06-12T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/kineta-seattle-childrens-research-institute-collaborate-to-develop-medications-for-autoimmune-diseases-120614-4291903/ 2014-06-12T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ruiyi-ihuman-institute-enter-research-collaboration-for-new-antibodies-targeting-gpcrs-120614-4291936/ 2014-06-12T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-secures-notice-of-allowance-for-us-patent-covering-new-celiac-disease-treatment-120614-4291959/ 2014-06-12T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/xenetic-doses-first-patient-on-dialysis-in-phase-ii-trial-of-erepoxen-120614-4292062/ 2014-06-12T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-to-launch-authorized-generic-version-of-testim-120614-4291974/ 2014-06-12T08:56:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-enters-into-232m-asthma-drug-deal-with-synairgen-130614-4292315/ 2014-06-12T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/hyperion-therapeutics-closes-acquisition-of-andromeda-biotech-130614-4292911/ 2014-06-13T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/parion-santen-pharma-to-develop-p-321-for-dry-eye-disease-130614-4292929/ 2014-06-13T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-gets-us-patent-covering-rnai-therapeutics-to-treat-hepatitis-b-virus-infection-130614-4292944/ 2014-06-13T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ferrer-begins-second-phase-iii-study-for-ozenoxacin-130614-4292962/ 2014-06-13T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvisan-pharma-opts-for-alphadas-to-accelerate-clinical-development-processes-130614-4292982/ 2014-06-13T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/oncobiologics-gets-dutch-competent-authority-nod-to-begin-phase-i-trial-for-ons-3010-130614-4293029/ 2014-06-13T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-merck-serono-to-develop-new-therapeutic-antibodies-130614-4293076/ 2014-06-13T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-to-conduct-clinical-trials-of-vyvanse-in-preschool-age-children-with-adhd-130614-4293093/ 2014-06-13T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-actonel-tablets-150mg-130614-4293114/ 2014-06-13T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-viiv-healthcare-to-develop-two-drug-single-tablet-regimen-for-hiv-1-130614-4293174/ 2014-06-13T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-launches-takelda-combination-tablets-in-japan-for-peptic-ulcers-130614-4293146/ 2014-06-13T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-releases-positive-results-from-phase-iii-petit2-study-of-eltrombopag-160614-4293406/ 2014-06-15T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/affymax-takeda-to-terminate-omontys-product-collaboration-and-license-agreement-160614-4294274/ 2014-06-16T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/baron-and-budd-reaches-177m-settlement-for-seven-states-against-glaxosmithkline-160614-4293976/ 2014-06-16T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-medtronic-to-form-strategic-alliance-in-diabetes-160614-4293989/ 2014-06-16T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-releases-preliminary-clinical-results-from-phase-ii-study-of-tg-1101-160614-4294011/ 2014-06-16T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-introduces-global-registry-of-patients-with-type-2-diabetes-160614-4294015/ 2014-06-16T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-stops-enrollment-dosing-in-phase-i-vantictumab-and-fzd8-fc-trials-160614-4294021/ 2014-06-16T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharm-therapeutics-enters-into-preferred-provider-agreement-with-veristat-160614-4294067/ 2014-06-16T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-gadavist-injection-gets-fda-approval-as-mri-contrast-agent-160614-4294093/ 2014-06-16T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-exercises-option-to-license-ag-221-under-global-strategic-collaboration-160614-4294123/ 2014-06-16T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-navideas-lymphoseek-for-expanded-use-in-head-and-neck-cancer-patients-160614-4294154/ 2014-06-16T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-and-lilly-report-positive-results-from-two-phase-iii-trials-of-diabetes-drug-empagliflozin-170614-4294504/ 2014-06-16T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-selects-pristima-for-drug-safety-rd-data-management-solution-170614-4295211/ 2014-06-17T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-gets-patent-in-india-for-cell-therapy-production-methods-and-compositions-170614-4295465/ 2014-06-17T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/nutroganics-files-with-otc-markets-to-remove-stop-sign-170614-4295495/ 2014-06-17T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/vistagen-gets-notice-of-allowance-for-canadian-patent-expanding-stem-cell-technology-platform-170614-4295490/ 2014-06-17T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-selects-trial-interactive-platform-as-etmf-solution-170614-4295315/ 2014-06-17T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/avion-gets-positive-feedback-from-fda-on-two-ndas-170614-4295319/ 2014-06-17T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-licensed-novartis-holly-springs-facility-for-cell-culture-influenza-vaccines-production-170614-4295553/ 2014-06-17T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-expands-global-sales-with-initial-order-from-hardcore-beverages-170614-4295575/ 2014-06-17T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-opens-new-research-and-development-site-in-cambridge-us-170614-4295619/ 2014-06-17T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-gets-fda-approval-for-codeine-sulfate-tablets-170614-4295602/ 2014-06-17T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-submits-meningococcal-b-vaccine-bla-180614-4296990/ 2014-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amvac-begins-phase-iii-trial-of-gynevac-vaccine-for-bacterial-vaginosis-180614-4295832/ 2014-06-17T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/bellerophon-completes-patient-enrollment-for-phase-2-trial-of-inopulse-180614-4295993/ 2014-06-18T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-pharmas-amitiza-receives-nice-recommendation-180614-4296216/ 2014-06-18T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-lilly-announce-resubmission-of-new-drug-application-to-fda-for-empagliflozin-180614-4296242/ 2014-06-18T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-reaches-settlements-in-nuvigil-patent-case-180614-4296249/ 2014-06-18T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/psioxus-therapeutics-initiates-octave-study-180614-4296261/ 2014-06-18T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-outcome-technologies-receives-orphan-drug-designation-for-coti-2-180614-4296271/ 2014-06-18T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-receives-fda-orphan-drug-designation-for-soliris-180614-4296408/ 2014-06-18T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-marketing-authorization-applications-for-abbvies-genotype-1-chronic-hepatitis-c-regimen-180614-4296541/ 2014-06-18T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-symplmeds-prestalia-nda-180614-4296652/ 2014-06-18T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/dnatrixs-dnx-2401drug-receives-fda-fast-track-status-180614-4296723/ 2014-06-18T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/pharma-technology-focus-now-available-as-a-tablet-app-190614-4296936/ 2014-06-18T23:25:00+00:00 https://www.pharmaceutical-business-review.com/news/nephrogenex-initiates-patient-enrollment-in-first-pyridorin-phase-iii-trial-190614-4297001/ 2014-06-18T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/3sbio-licenses-pegsiticase-to-selecta-biosciences-to-develop-new-drug-for-gout-treatment-190614-4297254/ 2014-06-19T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-announces-phytofare-can-be-used-as-dietary-supplement-without-prior-fda-approval-190614-4297322/ 2014-06-19T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/radient-gets-site-license-from-health-canada-to-manufacture-natural-health-products-in-edmonton-190614-4297336/ 2014-06-19T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/keryx-gets-two-us-patents-for-zerenex-covering-orally-administrable-forms-of-ferric-citrate-190614-4297352/ 2014-06-19T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-completes-pbi-4050-phase-i-clinical-trial-190614-4297367/ 2014-06-19T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cipher-andrmaco-ink-supply-agreement-for-isotretinoin-capsules-in-chile-190614-4297578/ 2014-06-19T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/american-cryostem-nanoranch-to-create-new-cancer-treatment-delivery-methods-190614-4297761/ 2014-06-19T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-cellectis-enter-into-cancer-immunotherapy-collaboration-190614-4297842/ 2014-06-19T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-vertex-ink-license-deal-to-develop-new-influenza-a-treatment-190614-4297874/ 2014-06-19T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/uniqure-medison-sign-distribution-agreement-for-glybera-190614-4297898/ 2014-06-19T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/trilink-gets-patents-for-new-ligation-technology-in-us-europe-and-new-zealand-200614-4299533/ 2014-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cea-leti-akrivis-to-develop-manomedicine-platform-for-high-payload-targeted-drug-delivery-200614-4299546/ 2014-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-terminates-global-prostate-cancer-therapy-development-200614-4298095/ 2014-06-19T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-seeks-fda-approval-for-ceftolozanetazobactam-200614-4298240/ 2014-06-20T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/cdc-lab-determines-possible-anthrax-exposures-200614-4298308/ 2014-06-20T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/glycomimetics-initiates-first-clinical-trial-of-gmi-1271-as-potential-treatment-for-blood-related-cancers-200614-4298416/ 2014-06-20T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/navitor-pharmaceuticals-announces-235m-series-a-financing-200614-4298425/ 2014-06-20T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-initiates-two-clinical-studies-200614-4298434/ 2014-06-20T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-pharmaceuticals-to-regain-worldwide-rights-to-develop-and-commercialize-mm-121-200614-4298441/ 2014-06-20T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-begins-phase-i-study-of-debio-1450-200614-4298614/ 2014-06-20T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/macrogenics-starts-phase-1-trial-of-mgd006-for-acute-myeloid-leukemia-200614-4298737/ 2014-06-20T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/cepheid-pharma-firms-collaborate-on-diagnostic-test-for-multidrug-resistant-bacterial-infections-200614-4298835/ 2014-06-20T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-gets-fda-approval-for-sivextro-to-treat-serious-skin-infections-230614-4299110/ 2014-06-22T23:15:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-reaches-settlement-with-perrigo-catalent-in-proair-hfa-patent-case-4299561/ 2014-06-23T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/cara-therapeutics-doses-first-patient-in-phase-iaib-trial-of-cr845-to-treat-acute-chronic-pain-230614-4299646/ 2014-06-23T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-initiates-tender-offer-to-acquire-idenix-230614-4299650/ 2014-06-23T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-gets-patent-in-russia-to-treat-inflammatory-bowel-disease-using-placenta-derived-cells-230614-4299666/ 2014-06-23T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/igi-laboratories-files-seventh-anda-in-2014-to-us-fda-230614-4299865/ 2014-06-23T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/stemcells-closes-patient-enrollment-in-phase-iii-dry-amd-trial-230614-4299891/ 2014-06-23T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/celsion-acquires-biopharmaceutical-firm-egen-230614-4299961/ 2014-06-23T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-inks-collaboration-research-agreement-with-st-jude-childrens-research-hospital-230614-4299572/ 2014-06-23T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/kadmon-begins-phase-iia-portion-of-kd020-trial-in-autosomal-dominant-polycystic-kidney-disease-230614-4300031/ 2014-06-23T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-roche-partner-to-discovery-new-nanomedicines-230614-4300038/ 2014-06-23T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-begins-phase-iiia-cervical-cancer-trial-of-ino-3112-240614-4300207/ 2014-06-23T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-in-licenses-new-compound-to-treat-neuropathic-pain-240614-4300808/ 2014-06-24T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/endexx-to-test-autospense-technology-in-colorado-market-240614-4300879/ 2014-06-24T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/servier-miragen-extend-research-collaboration-on-microrna-targeting-drugs-240614-4300901/ 2014-06-24T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/inform-genomics-enters-into-strategic-collaboration-with-translational-drug-development-240614-4300935/ 2014-06-24T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/madison-vaccines-starts-phase-ii-trial-of-dna-vaccine-mvi-816-to-treat-prostate-cancer-240614-4300954/ 2014-06-24T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-files-ind-application-to-begin-phase-ii-trial-of-ipf-drug-erivedge-240614-4301051/ 2014-06-24T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-dimension-to-develop-novel-gene-therapy-for-hemophilia-a-240614-4301079/ 2014-06-24T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-orphan-drug-status-to-triphases-myeloma-drug-marizomib-240614-4301119/ 2014-06-24T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/alimeras-iluvien-gets-marketing-authorization-in-italy-to-treat-chronic-dme-240614-4301148/ 2014-06-24T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bionomics-enters-into-research-collaboration-with-merck-for-bnc375-research-program-240614-4301177/ 2014-06-24T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-agrees-to-buy-russian-pharmaceutical-firm-veropharm-240614-4301224/ 2014-06-24T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-ligand-ink-licensing-deal-to-develop-inhibitors-of-irak4-250614-4301575/ 2014-06-24T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-to-introduce-new-protein-meal-replacement-products-in-late-2014-250614-4301858/ 2014-06-25T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/orion-signs-agreement-for-aurigenes-pan-bet-selective-bet-bromodomain-inhibitors-250614-4301888/ 2014-06-25T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cook-pharmica-selexis-establish-biologic-drug-development-platform-250614-4302126/ 2014-06-25T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-tcg-lifesciences-complete-first-phase-of-research-collaboration-on-discovery-of-new-antibiotics-250614-4302236/ 2014-06-25T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/gelstat-inks-distribution-deal-with-windmill-health-products-250614-4302250/ 2014-06-25T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/engeneic-launches-clinical-development-strategy-for-edv-nanocell-technology-250614-4302318/ 2014-06-25T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-duke-university-collaborate-on-clinical-trial-transparency-250614-4302363/ 2014-06-25T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-gets-us-patent-for-bi-505-development-of-apoptosis-inducing-icam-1-antibodies-250614-4302390/ 2014-06-25T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-international-agrees-to-buy-dava-pharma-for-575m-250614-4302421/ 2014-06-25T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/mersana-emd-serono-to-develop-new-antibody-drug-conjugates-250614-4302442/ 2014-06-25T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-gets-allowance-from-uspto-for-two-cancer-immunotherapy-patent-applications-250614-4302464/ 2014-06-25T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/quark-doses-first-patient-in-phase-iia-trial-of-glaucoma-drug-candidate-qpi-1007-260614-4302850/ 2014-06-25T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/sobi-seeks-ema-approval-for-xiapex-for-peyronies-disease-260614-4303183/ 2014-06-26T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/eastgate-gets-ontario-brain-institute-research-grant-to-develop-lorazepam-spray-260614-4303212/ 2014-06-26T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicomm-signs-multi-year-agreement-with-top-cros-for-trialone-260614-4303554/ 2014-06-26T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/itonis-authorizes-start-of-emesyl-inaugural-production-run-260614-4303572/ 2014-06-26T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bone-therapeutics-initiates-phase-iiia-trial-of-allob-to-treat-delayed-union-fractures-260614-4303591/ 2014-06-26T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-reports-top-line-data-from-phase-iii-trial-of-zubsolv-to-treat-opioid-dependence-260614-4303610/ 2014-06-26T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/aerie-pharmas-phase-iib-trial-of-roclatan-meets-primary-efficacy-endpoint-260614-4303629/ 2014-06-26T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-sorrento-to-develop-morphotek-antibody-drug-conjugates-260614-4303745/ 2014-06-26T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/insys-cannabidiol-gets-fda-orphan-drug-status-for-lennox-gastaut-syndrome-260614-4303926/ 2014-06-26T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/tni-biotech-signs-non-exclusive-distribution-agreement-for-lodonal-in-africa-260614-4303930/ 2014-06-26T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zs-pharma-begins-patient-enrollment-in-phase-iii-trial-of-zs-9-for-hyperkalemia-treatment-270614-4304126/ 2014-06-26T23:09:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-nobelex-to-develop-new-antibiotics-for-n-gonorrhoeae-and-enteric-species-270614-4304560/ 2014-06-27T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-initaites-phase-iia-trial-of-oncology-drug-candidate-bal101553-270614-4304865/ 2014-06-27T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/nutrafuels-becomes-dtc-eligible-and-dwac-approved-270614-4304888/ 2014-06-27T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/rosetta-gets-notice-of-allowance-for-us-patent-for-prognosis-prostate-cancer-treatment-270614-4304902/ 2014-06-27T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-exemption-allows-plandai-to-start-sales-of-first-phytofare-product-270614-4304951/ 2014-06-27T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-launch-of-mabthera-sc-triggers-milestone-payment-to-halozyme-therapeutics-270614-4304966/ 2014-06-27T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-biotechnology-gets-notice-of-patent-for-lead-drug-candidate-ac-201-in-us-270614-4304998/ 2014-06-27T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/liomont-oncobiologics-to-develop-new-biosimilar-products-in-mexico-270614-4304742/ 2014-06-27T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-begins-phase-iib-trial-of-voclosporin-to-treat-lupus-nephritis-270614-4305122/ 2014-06-27T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-idarucizumab-gets-fda-breakthrough-therapy-status-4305207/ 2014-06-27T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bellerophon-completes-patient-enrollment-in-phase-ii-trial-of-inopulse-to-treat-ph-copd-270614-4305189/ 2014-06-27T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-takeda-collaborate-for-diabetes-awareness-and-education-in-japan-010714-4307158/ 2014-06-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-approval-of-roches-ovarian-cancer-drug-avastin-in-eu-300614-4305459/ 2014-06-29T23:27:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-oncology-reports-results-from-phase-iii-recourse-trial-of-anti-cancer-drug-tas-102-300614-4306099/ 2014-06-30T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-files-eu-marketing-application-for-velcade-to-treat-mantle-cell-lymphoma-300614-4306107/ 2014-06-30T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerons-eylea-injection-recommended-for-eu-approval-to-treat-visual-impairment-due-to-dme-300614-4306121/ 2014-06-30T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-gets-chmp-positive-opinion-for-kalydeco-in-eight-non-g551d-gating-mutations-300614-4306129/ 2014-06-30T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-and-pfizer-get-ema-committee-positive-opinion-for-eliquis-to-treat-dvt-pe-300614-4306145/ 2014-06-30T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/essentialis-doses-first-patient-in-clinical-trial-of-dccr-300614-4306232/ 2014-06-30T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcares-triumeq-gets-chmp-positive-opinion-in-europe-for-hiv-treatment-300614-4306271/ 2014-06-30T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/mannkind-gets-fda-approval-for-afrezza-for-treatment-diabetes-300614-4306301/ 2014-06-30T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-and-boehringers-insulin-glargine-gets-chmp-recommendation-for-approval-in-eu-300614-4306402/ 2014-06-30T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-invests-in-stratos-genomics-to-further-develop-sequencing-by-expansion-method-300614-4306426/ 2014-06-30T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-submit-snda-to-fda-for-fluticasone-furoatevilanterol-to-treat-asthma-010714-4306663/ 2014-06-30T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-issues-nationwide-recall-of-coumadin-for-injection-010714-4307144/ 2014-07-01T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/icon-bioscience-closes-patient-enrollment-in-phase-iii-trial-of-ibi-10090-010714-4307316/ 2014-07-01T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-launches-qudexy-xr-capsules-to-treat-specific-seizure-types-010714-4307244/ 2014-07-01T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/aqua-pharmaceuticals-launches-cordran-ointment-flurandrenolide-ointment-usp-010714-4307182/ 2014-07-01T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-updated-labeling-for-gattex-for-injection-to-include-long-term-data-010714-4307261/ 2014-07-01T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fsc-laboratories-to-market-aciphex-sprinkle-capsules-in-us-010714-4307441/ 2014-07-01T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/brickell-biotech-enters-into-licensing-deal-with-merz-for-new-retinoid-therapy-010714-4307484/ 2014-07-01T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-strategics-eisai-ink-licensing-deal-for-oncology-drug-010714-4307513/ 2014-07-01T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-acquires-phase-ii-oncology-drug-mesupron-from-wilex-010714-4307561/ 2014-07-01T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/glycovaxyn-begins-phase-i-trial-for-vaccine-to-treat-urinary-tract-infections-020714-4311053/ 2014-07-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-gets-approval-for-lemtrada-in-argentina-to-treat-multiple-sclerosis-020714-4307809/ 2014-07-01T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/emerald-completes-latest-financing-launches-emerald-cloud-lab-020714-4308161/ 2014-07-02T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-reports-primary-endpoint-result-for-phase-iii-trial-of-rifaximin-020714-4308171/ 2014-07-02T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-completes-acquisition-of-forest-laboratories-020714-4308183/ 2014-07-02T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/cortex-pharma-enters-into-license-agreement-with-university-of-illinois-020714-4308192/ 2014-07-02T04:43:00+00:00